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Preface 
In this dissertation, a report of my PhD research activity is provided. The 
activity was carried out in Biotech Research Center, part of the Industrial 
Engineering Department, of the University of Trento (Italy), under the supervision 
of Prof. Claudio Migliaresi and Dr. Devid Maniglio. 
Biofabrication, an approach to the bottom-up paradigm of tissue engineering, 
represent the research topic. This technology is defined as the production of 
complex biological constructs using cells, components of the ECM, biomolecules 
and biomaterials that are assembled with different techniques in an engineered 
tissue fragment. The general aim of the work was to address some of the problems 
that currently limited the development and applicability of biofabrication. In 
particular, two issues were considered in the experimental part: the 
cryopreservation of cell-laden hydrogel constructs and the development of novel 
building blocks containing cells using alginate-based hydrogels. Alginate was the 
material of choice for investigation, as an accepted support for different tissue 
engineering applications that can sustain several modification and fabrication 
methods. 
In the first chapter, the concepts of bottom up tissue engineering and 
biofabrication are introduced. The role and state of the art of hydrogels to 
manufacture cell-laden building blocks, the techniques for cell encapsulation and 
the commonly used fabrication strategies for biofabrication and bioprinting are 
reviewed together with their applications. Moreover, the limitations that currently 
restrict the applicability of hydrogel-based tissue engineering are discussed. 
In chapter two, the role of alginate hydrogels in tissue engineering and 
biofabrication is described. In particular, its chemical content, crosslinking 
behavior, manufacturing capacity and applications are reviewed with emphasis on 
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the possible modification of alginate hydrogels in order to enhance 
biocompatibility and functionality of encapsulated cells. 
The experimental part is described in the following chapters. Chapter three 
introduces the concept of cryopreservation, and in particular the issues concerning 
preservation of cell-laden building blocks. Subsequently, the impact of 
cryopreservation on the viability and functionality of cells encapsulated in alginate 
matrices is evaluated comparing different cryoprotective agents. The experimental 
methods for manufacturing and preserving cell-laden alginate fibers and for 
performing the biological and structural tests are reported. The results are 
presented, discussed and compared with the state of the art. 
In chapter four, a novel method for encapsulating cells within alginate-based 
hydrogel films with micrometer thickness is described. The procedure for 
immobilizing cells within hydrogel films with different composition is described, 
together with the performed biological assays aimed at selecting the best matrix 
composition. The results are reported and discussed, emphasizing the potential 
applications and future developments of the proposed method. 
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Chapter 1.  
Hydrogel based Biofabrication for Tissue 
Engineering and Regenerative Medicine 
In this chapter, the use of hydrogels for cell culture will be introduced. The 
concept of tissue engineering, biofabrication, cell encapsulation and bioprinting 
will be discussed focusing on the role of hydrogels and considering both the 
manufacturing techniques and the applications of these technologies. In particular, 
the role of cell-laden hydrogels as building blocks for assembling complex 3D 
tissue-like constructs will be reviewed. Finally, current limitations and future 
perspective of hydrogel-based bottom-up tissue engineering will be discussed. 
1.1 Introduction 
Our ability to understand the biological mechanism that underlie many cell-
based processes, such as migration, differentiation and force-sensing, is derived 
from studies performed on two-dimensional (2D), unphysiologically stiff materials 
like glass and plastic surfaces (fig. 1a). However, cells in vivo are likely to operate 
within a complex and hierarchical environment that contains multiple extracellular 
matrix (ECM) components, mixed cell populations and complex regulatory signals. 
Cells cultured in traditional monolayer substrates can differ substantially from 
those grown in more relevant 3D environment in terms of morphology, cell-cell 
and cell-matrix interaction, response to pharmaceutical reagents and 
differentiation pathway. Therefore, culture systems that better mimic the biological 
milieus are needed to bridge the gap between conventional cultures and complex 
native in vivo environments 1–3. A range of biomaterials have been developed toward 
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the introduction of this complexity into cell culture systems, providing ways to 
control chemical, mechanical, compositional and topographical cues thus more 
accurately represent features of native tissues. Hydrogels, crosslinked networks that 
possess high water content, have emerged as the most promising option matrices 
for cell culture as they recapitulate aspects of the native cellular microenvironment 
3–5. 
1.2 Hydrogels as extracellular matrix mimic 
Hydrogels are three-dimensional networks of hydrophilic homopolimers, 
copolymers of macromonomers, crosslinked to form insoluble polymer matrices. 
The three-dimensional structure of the polymer network is stabilized either by 
chemical cross-linking (covalent bonds) or physical cross-linking (entanglement, 
crystallites, ionic and hydrogen bonds). A wide range of natural or synthetic 
polymer compositions and crosslinking techniques have been used to fabricate and 
functionalize hydrogels with biological and biochemical cues 4–6. Among their 
advantages are the possibility to control and modulate the swelling and degradation 
kinetics, the mechanical and the diffusion properties by regulating the chemistry of 
the polymeric backbone, its hydrophilicity, the swelling degree and the crosslinking 
density. Thus, their biological interaction with cells can be tailored depending on 
the application 6,7. 
Hydrogels are by definition capable of binding large quantities of water and 
possess facile transport of oxygen, nutrients and waste, as well as realistic transport 
of soluble factors 2. Therefore, they may promote the cell population to exhibit 
phenotypes more similar to those found in native tissues than when the cells are 
grown in monolayer culture (fig. 1b). These ECM-like properties allow cell 
encapsulation in a highly hydrated, mechanically supportive 3D environment; 
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making them attractive for regenerative medicine and other biomedical 
applications 2,3. Since the formation of many hydrogels can occurs under mild, 
cytocompatible conditions, they are often used in conjunction with cell micro-
encapsulation technologies, which consists in the immobilization of viable cells 
within a permeable tridimensional construct 8,9. 
 
Figure 1. (a) conventional 2D cell culture on unphysiological stiff plastic or glass 
substrates leads to cells displaying aberrant phenotypes. (b) Engineered hydrogels 
can be used to recapitulate a more realistic 3D microenvironemt to encapsulated 
cells. Hydrogels design variables are indicated considering the typical physiological 
cues of the extracellular matrix (ECM). Adapted from 3. 
Hydrogels are suitable for a wide range biomedical and pharmaceutical 
application, for example contact lenses, wound dressing and carrier for drug 
delivery 4. Furthermore, due to their unique biocompatibility, excellent diffusion 
properties, range of constituents and desirable physical characteristic, they have 
been the material of choice for many applications in tissue engineering. They can 
b
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serve as scaffold that provide structural integrity to tissue constructs, control drug 
and protein delivery to tissue and cultures and serve as barriers between tissue and 
material surface 4,7,10. 
1.3 Definitions and recent developments of tissue engineering 
Tissue engineering (TE), a major component of regenerative medicine, aims 
to functionally replace lost and/or damaged tissues, through the combination of 
bioactive materials with cells to generate engineered constructs 11–13. TE aims to 
overcome the limitations of current treatments based on organ transplantation by 
generating ‘artificial’ organs and tissue substitutes that can grow along with the 
patient 11,14. This discipline has evolved as an interdisciplinary technology 
combining principles from the life, material and engineering sciences for the 
development of biological substitutes that restore, maintain or improve tissue 
function or a whole organ and for the production or realistic tissue constructs for 
in vitro applications 14,15. TE has emerged not only for overcoming the limitations 
of current treatments based on organ transplantation but also for generating tissue-
engineered surrogates that could be useful for drug screening, chemical toxicity 
testing and basic cell biology studies 16,17. 
Traditional tissue engineering strategies employ a ‘‘top-down’’ approach, in 
which cells and growth factors are seeded in or onto biodegradable biomaterials to 
form constructs that can be immediately implanted or incubated in vitro prior to 
transplantation 17,18. These materials serve as temporary scaffolds and promote the 
reorganization of the cells to form a functional tissue 15. The top down approaches 
have been successfully used for the regeneration of thin avascular tissue over the 
past decades but are not yet suitable methods for generating 3D structures with 
physiological relevant size and a functional organization. In fact, the three-
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dimensional constructs that have been generated with these scaffold-based TE 
approaches are typically based on the random distribution of cells, matrix and 
bioactive cues since their manufacturing have difficulty recreating the intricate 
microstructural features of native tissues 17–19. 
To address this challenge, ‘bottom up’ tissue engineering aims to recreate 
biomimetic structures by designing structural features on the microscale to build 
modular units that can be used as building blocks to create larger tissues 19. This 
approach, termed “biofabrication”, relies on different additive manufacturing 
technology in order to pattern and assemble living and non-living material into bio-
engineered 3D structures to replicate the complex nature of native tissue 20–22 (fig. 
2a). Biofabrication technology encompasses a broad range of physical, chemical, 
biological, and/or engineering processes and demand contributions from different 
disciplines like cell and developmental biology, biomaterial science, and mechanical 
engineering 20. The paradigm of bottom up tissue engineering concept that involves 
biofabrication of a cell-laden construct is reported in fig. 2b 23. Cells are isolated 
from the patient and may be cultivated in vitro on two-dimensional surfaces for 
efficient expansion. Subsequently, the cells are combined with various biomaterials, 
small molecules and/or ECM fractions in order to generate a living scaffold. The 
scaffolds serve for harnessing the innate abilities of cells to sense their local 
environment through cell–cell and cell–extracellular matrix contacts and self-
assemble into a functioning tissue. Bioreactors can be used to provide optimal 
conditions during the maturation of the cell constructs 15. Cell-laden constructs can 
be used as in vitro model to study the interaction between different cells and 
bioactive molecules and to test drug or therapeutic procedures. Moreover, the 
biofabricated structures could also lead to functional tissue equivalents and 
potentially to whole functioning organs 17,18,22. 
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Figure 2. Biofabrication process, techniques, and applications. (A) Schematic of 
multiscale assembly strategies from bottom to top for engineering 3D tissue 
constructs. The assembly strategies can follow paths starting with biomolecules or 
cells and can be integrated in the engineering of the final 3D tissue constructs. 
Moreover, hydrogels can be introduced in the process to support mechanical stress 
and guide cells in an instructive microenvironment. Adapted from ref. 22. (B) For 
human therapeutic applications, the typical workflow of biofabrication involves the 
isolation and expansion of human cells prior to manufacturing the desired cell-laden 
scaffold. These scaffolds could then ultimately be transplanted as therapeutic devices 
themselves or used as a testing platform for drug screening and discovery or as an in 
vitro model system for diseases. Adapted from 23. 
In order to meet the increasing list of desirable traits of materials for 
biofabrication and tissue engineering in general, a variety of biomaterials have been 
developed to mimic specific cell and tissue niches 5,24. These includes polymers 
(natural and synthetic), ceramics and composites 24. In a recently published review, 
Murphy et al. reported a list of ideal material properties for biofabrication 25: 
A
B
B
iofabrication
Biomaterials
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• Biocompatibility. Materials should coexist with the endogenous 
tissue without inducing any undesirable local or systemic responses in the host and 
should contribute actively and controllably to the biological and functional 
components of the construct. This include supporting the appropriate cellular 
functions and facilitating molecular and mechanical signaling. 
• Degradation kinetics and byproducts. Degradation rates should 
match the ability of the cells to replace the materials with their own ECM. 
Degradation products should be nontoxic, readily metabolized and rapidly cleared 
from the body. Moreover, materials should demonstrate suitable swelling 
characteristics without resulting in loss of layer integrity or deformation of the final 
construct. 
• Structural and mechanical properties. Materials should be chosen 
based on the required mechanical properties of the constructs, as different 
structural requirements are needed for diverse tissue types. 
• Material biomimicry. Engineering of desired structural, functional 
and dynamic material properties should be based on knowledge of the naturally 
occurring tissue-specific composition and localization of ECM components in the 
tissue of interest. The incorporation of ECM components, the addition of surface 
ligands and the presence of nanoscale features has the potential to affect cell 
attachment, proliferation, cytoskeletal assembly and differentiation processes. 
• Handling and/or printability. Properties that facilitate handling and 
deposition may include viscosity, gelation methods and rheological properties. The 
choice of material may be also influenced by its ability to protect cell viability during 
the extrusion or printing of bioinks, assembling of multi-layered cellularized 
products, or weaving of fiber-based cell-laden modules. 
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The polymeric and ceramic materials that have been traditionally processed 
by additive manufacturing techniques typically require process parameters (e.g., 
high temperature, solvents, lack of water) that are not compatible with the direct 
inclusion of cells 24. Different classes of natural and synthetic hydrogels that gelate 
in mild conditions are thus gaining increasing interest for fabricating complex 3D 
cellular microenvironments; they can be tuned for ideal physicochemical 
properties, degradability and mechanics, and their high water content creates an 
environment conductive to the encapsulation of cells 24,26. 
The modules that serve as building blocks can be created in a number of ways, 
such as through self-assembled aggregation, creation of cell sheets, direct printing 
of cells and other supportive biomaterials, and microfabrication of cell-laden 
hydrogels 17,18. Commonly used hydrogels modules for cell encapsulation consist in 
beads 27, fibers 28,29 and films 30. Once created, these modules can be assembled into 
larger tissue constructs through a number of methods such as random packing, 
layer stacking or directed assembly17,18,26. 
1.4 Hydrogels as matrices for cell encapsulation 
Hydrogels represent one of the most common scaffolding material in tissue 
engineering and are used to provide bulk and mechanical constitution to a tissue 
construct, whether cells and bioactive compounds are adhered to or suspended 
within the 3D gel framework 9,31. Cell encapsulation consists in entrapping viable 
cells within a matrix which should allow cells viability while possibly supporting 
their growth, organization and metabolic activity 32,33 (fig. 3). 
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Figure 3. Schematic of the cell encapsulation into hydrogel beads (left) (adapted 
from 33) or fibers (right) (adapted from 34) This technique consists in enclosing cells 
and other biologically active materials within the polymeric matrix. The capsule 
interface allows the bi-directional diffusion of nutrients, oxygen, waste and 
therapeutic products, but prevents inflammatory cells and antibodies, which might 
destroy the enclosed cells, from entering the capsule. 
Major requirements for the encapsulating material are to allow diffusion of 
oxygen and nutrients towards the cells. In fact, hydrogels can encapsulate cells 
during the fabrication process unlike traditional scaffold that are fabricated and 
seeded with cells in two times 31 (fig. 4). Hydrogels possess many properties which 
are attractive as stand-alone tissue scaffolds or vehicles to deliver drugs, growth 
factors or cell therapies: cytocompatibility, tissue mimetic water content, support 
of cell migration and tissue integration, sustained release of growth factors and 
controllable physical properties 10,35.  
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Figure 4. Mechanism of crosslinking of an hydrophilic polymer into a 3D hydrogel. 
Cells can be encapsulated during gelation if they were suspended in the liquid 
polymer solution. Adapted from 31. 
Hydrogels used in tissue engineering applications are predominantly based 
on natural derived polymers, including alginate, gelatin, collagen, chitosan, silk 
fibroin, fibrin and hyaluronic acid, because of their inherent excellent 
cytocompatibility, low toxicity and susceptibility to enzymatic degradation 7. 
Natural hydrogels, derived from polysaccharide or proteins, offer inherent 
bioactivity except for agarose and alginate and display a chemical and structural 
resemblance to ECM 36. Synthetic hydrogels which lack biologic stimuli often 
require modification to introduce chemical and physical signals for instructive cell 
and tissue responses 10,37. 
Natural and synthetic hydrogels are particularly attractive for biofabrication 
as artificial ECM to generate physiologically relevant 3D scaffolds for cell and tissue 
growth. In fact, hydrogels are good candidates for encapsulating cells during their 
fabrication process: cell-laden hydrogel can serve as building blocks 17,37 or used in 
conjunction with a set of additive manufacturing techniques that go under the 
name of bioprinting 25,38. The principle of bioprinting can be defined as the use of 
automated 3D robotic technologies in order to place cell-laden materials into 
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spatially defined structures. The raw materials of bioprinting process, soft 
biomaterials loaded with living cells, are called ‘bioinks’ 38,39. Various key properties 
including concentration, molecular weight, viscosity, gelation kinetics and stiffness 
can be selected according to the specific bioink requirements 16,38,39. 
Moreover, hydrogels are also suitable to keep cells and fluid separate while 
allowing diffusion of soluble factors within their structure. This property can be 
used to encapsulate cells in micron to millimeter size capsules that can serve as 
delivery vehicles for cell-based therapies 9,32. These microcapsules can also be 
engineered to allow for the diffusion of nutrients and removal of metabolites, while 
prohibiting interaction of encapsulated cells with the immune system, therefore 
avoiding the rejection of the implant by the host 32,33. Therefore, encapsulation of 
cell offers several potential applications as the encapsulated cells can be 
transplanted within a host where they secrete specific disease treating molecules 
(e.g. against diabetes 40, anemia 41 or hemophilia 42). 
When cellular adhesion directly to the gel is favored over suspension within 
the scaffold, incorporation of various active components into the hydrogel structure 
can dramatically increase the tendency for cellular attachment 7. For this reason, 
specific peptide domains have been incorporated into the matrix material for 
improved cell adhesion, enhanced cell proliferation, or differentiation. For 
example, ECM proteins bind to soluble growth factors and regulate their 
distribution, activation and presentation to cells. In fact, cell-ECM interactions are 
extremely complex in nature, and consequently there is a need for a biomimetic 
approach to create the native setting for the cells 1,15. A particular successful strategy 
to mediate cellular attachment is the inclusion of the RGD (arginine-glycine-
aspartic acid) adhesion peptide sequence into the matrix. Cells that have been 
shown to favorably bind to RGD include fibroblasts, endothelial cells (ECs), smooth 
muscle cells (SMCs), osteoblasts, and chondrocytes. RGD in hydrogels, which can 
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be incorporated on the surface or throughout the bulk of the gel, has shown 
enhanced cellular migration, proliferation, growth and organization in tissue 
regeneration applications 7. 
1.4.1 Methods for cell encapsulation 
The entrapment of cells in a hydrogel construct usually starts by suspending 
cells in a water-based solution of hydrogel precursor, the sol phase. The cell-laden 
suspension then undergoes a sol gel transition by physical, chemical or biochemical 
processes. During the entire process, the environmental conditions should not 
damage the suspended cells being as close as possible to the physiological 
environment 5,31. Various methods for encapsulating cells within natural or 
synthetic-derived microgels have been proposed in the last years. Cells have been 
encapsulated in microbeads by means of bio-electrospray methods (fig. 5a) 27, with 
microfluidic-based techniques 43, or by using superhydrophobic surfaces as 
substrates for crosslinking hydrogel droplets at liquid-air interface (fig. 5b). 
Moreover, fiber-shaped structures containing cells have been produced using 
electro-spinning (fig. 5c), extrusion-based methods (wetspinning) (fig. 5d), 
microfluidic spinning (fig. 5e) or other techniques 29,38. Other methods to generate 
cell-laden hydrogel building blocks with specific microarchitecture range from 
emulsification to photolithography, scanning soft lithography and micromolding 7. 
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Figure 5. schematic of various methods for manufacturing cell-laden hydrogel 
modules. (a) bio-electrospraying methods permits to create sub-millimeter beads by 
spraying a polymer solution pumped through a needle connected to a high-voltage 
generator. Cell-laden droplets of the jet can be collected in a coagulation bath in 
order to cause hardening (adapted from 5). (b) the principle of preparing hydrogel 
spheres using a super- hydrophobic substrate (top), a SEM micrograph of a 
representative superhydrophobic polystyrene substrate (bottom left) and a typical 
formation process for chitosan hydrogel spheres from the liquid drops on the 
substrate (bottom right) (adapted from 44). (c-e) various technique for encapsulating 
cells in fibers for TE (adapted from 29) (c) In electrospinning, an electric field is used 
to drawn fibers by the flow of a viscoelastic polymer subjected to an applied electric 
field (d) fibers in wetspinning are formed by extruding a pre-gel solution into a 
coagulation bath by using a syringe needle or micronozzle array; (e) microfluidic 
platforms produce fibers by coaxial flow of a pre-polymer and a crosslinking agent. 
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1.5 Fabrication strategies for bottom-up tissue engineering 
Many different methods for producing 3d culture systems with relevant size 
have been proposed in the last decade. Bottom-up tissue engineering aims at 
recreating tissue complexity within engineered constructs, using microfabricated 
gels as building blocks 7. Compared with scaffold-based tissue engineering, bottom-
up methods allows manipulation of hundreds to thousands of cells per modules 22. 
This approach relies on the concept of repeating functional units that are present in 
native tissues. The building blocks that serve as functional units can be assembled 
in packed structures having natural tissue like complexity and function according 
to different techniques. These strategies, ranging from weaving of fiber-like 
modules 28,29 to layer-by layer overlay of films 17,45,46, are selected according to the 
tridimensional architecture and composition of the tissue. The hydrogel blocks can 
range from tens to hundreds of micrometers and typically comprise encapsulated 
cells within each module 37.  
1.5.1 Assembly of cell-laden modules 
In a recently published review, Pati and colleagues presented an evolution of 
the cell-culture models developed in the last decades, starting from 2d cultures to 
cell cultures on hydrogel membranes, sandwich cultures, to 3D cultures and 
bioprinting approaches 16 (fig. 7). For all these strategies, hydrogels are the 
frameworks that allow cell encapsulation in order to create building blocks for 
subsequent assembling or printing of cell-laden constructs 31,37. 
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Figure 7. Evolution of cell-culture models. 2D cell cultures have been used for many 
years and is still being used for simple cell-based assays. Membrane and sandwich 
cultures were later developed. Hydrogels are usually used to culture encapsulated 
cells in three dimensions. Spheroid cultures are used as a scaffold-free culture where 
cell–cell interactions are predominant. 3D scaffolds are produced by various 
techniques, and cells are subsequently seeded on them. The advent of 3D printing 
and other additive manufacturing techniques encouraged the fabrication of complex 
structures in a reproducible manner, with control over their architecture and 
composition. However, cells are still seeded on the scaffolds after fabrication. 3D 
bioprinting technology, whereby cell-laden hydrogels can be included in the printing 
process in the form of bioinks, enables the fabrication of cell-laden constructs. 
Interestingly, the cellular microenvironment can be modulated with these 
techniques. To date, 3D bioprinting is the most sophisticated technique to fabricate 
tissue/organ constructs. Adapted from 16. 
In this framework, hydrogel can be used as substrates for the generation of 
2D cell sheets or used to encapsulate cells directly during the fabrication process. 
The first approach allow the subsequent detachment of the cell sheet from the 
hydrogel substrates and the layer by layer assembly of multiple sheets in order to 
create a 3D construct 47,48. The cell sheet-based tissue engineering technology allows 
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for a scaffold-free sheet of interconnected cells in contact with their natural ECM 
to be obtained and enables transplanted cell to be engrafted for a long time 47,48. The 
formation of layered tissues relies on the use of temperature-responsive hydrogel 
surfaces (eg. gelatin) or different stimuli that have been utilized to facilitate cell 
sheet detachment from the culture substrate 49. In contrast, encapsulating cell 
within the hydrogel permits the direct manipulation of cell-laden building blocks 
into designed architectures and spatial organizations 22,50. Various approaches to 
assemble microgels into designed architectures and spatial organization have been 
developed in the last decade. These assembly technologies are based on different 
techniques and can be classified according to the interaction modes between the 
microgels and the guiding forces: i) self-assembly, ii) guided assembly and iii) direct 
assembly 22. Moreover, different strategies can be combined together in order to 
increase the level of organization of biological components within an engineered 3d 
tissue structure. The combination of bioprinting, cell sheet technology, cell 
encapsulation and micro-, nano-patterning techniques using cells, hydrogels and 
biochemical cues could be promising to engineered tick tissues that feature a 
functional histoarchitecture 17,24. 
1.5.2 Bioprinting 
Bioprinting technique were developed in order to overcome some limitations 
of cell modules assembling approach, such as the difficulty in generating more 
complex structures comprising different cell types. Bioprinting is an additive 
manufacturing technique during which small units of biomaterials and biologics, 
including living cells, nucleic acids, drug particles, proteins and growth factors are 
dispensed with micrometer precision to form tissue-like structures 23,25 (fig 6). Using 
cell printers, hydrogel gelation occurs in situ, thus enabling precise control over 
spatial and temporal distribution of cells and ECM 38. The advantages of this process 
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thus include accurate control of spatial heterogeneity, physical properties, cellular 
composition and ECM organization, scalability and cost-effectiveness 38,51,52. The 
three major bioprinting techniques are based on inkjet, laser-assisted and extrusion 
methods, each having specific strengths, weaknesses, and limitations 23. These 
methods are briefly described in fig. 6. 
 
Figure 6. Overview and main components of the most widespread bioprinting 
approaches. (A) Inkjet printers eject small droplets of cells and hydrogel sequentially 
to build up tissues using thermal or piezoelectric valves to control the inkjet flow. (B) 
Laser-assisted bioprinters use a laser focused on an absorbing layer to generate 
pressures that propel cell-containing materials onto a collector substrate. (C) 
Extrusion bioprinters use pneumatic or mechanical (piston or screw) dispensing 
system to continuously extrude a liquid cell–hydrogel solution. Adapted from 38. 
In the past 10 years, bioprinting has been widely used in fabrication of living 
tissues, and bioprinters and bioprinted tissues have gained significant interest in 
medicine and pharmaceutics 53. In fact, this technology has a broad utility in various 
application areas such as tissue engineering and regenerative medicine 54,55, 
transplantation and clinics 56, drug screening and high-throughput assays 57 and 
cancer research 53. Basically, the concept of biofabrication can be divided into three 
steps 16: 
Inkjet Bioprinting
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1) preprocessing for preparation of the building blocks (consisting of 
cell encapsulated in hydrogel-based modules) or the bio-ink; 
2) the processing step, which typically involves the assembly of the 
microgel modules or the printing of a 3D structure; 
3) post-processing, where the fabricated construct is cultured in an 
incubator or bioreactor to induce maturation and transformation into a functional 
tissue. 
1.6 Applications of hydrogels in tissue engineering 
Hydrogels have a central role in regenerative medicine because of their 
capability to encapsulate cells in an instructive ECM-like environment and to be 
processed with different techniques in order to obtain 3D microstructured 
constructs. Tissue manufacture and the application of cell-laden hydrogel 
constructs have predominantly been discussed from a regenerative medicine 
perspective. However, the fabrication of tissue-like constructs based on bioprinting 
or other additive manufacturing techniques can also be beneficial to the fields of 
drug discovery and testing, and for studying disease processes and developmental 
biology 9. In this section, a list of applications is reported. A schematic of different 
types of hydrogel constructs fabricated with a range of bioprinting and additive 
manufacturing methods is reported in fig. 8 39. 
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Figure 8. Hydrogel based scaffolds and bioprinted constructs: (A) bioprinted 
agarose filaments 58; (B) 3D printed alginate in brain shape 59 (C) chitosan scaffold 
60; (D) collagen type I construct for skin tissue regeneration (adapted from 61); (E) 
fibrin bioprinted tubular scaffolds 59; (F) deposited cells using gelatin bioprinted 
template 62; (G) 3D ‘half-heart’ scaffold bioprinted using alginate/gelatin 63; (H) 
bioprinted hyaluronic acid 64; (I) hepatic carcinoma cell-laden Matrigel graft 57; (J) 
confocal image of cells in a GelMA (gelatin metacrilate) scaffold 65; (K) bioprinted 
Pluronic® F- 127 fluorescent tube 66; (L) PEG (Poly(ethylene glycol)) hydrogel 
bioprinted into an aortic valve construct 67. Adapted from 39. 
1.6.1 Biofabrication for tissue regeneration and regenerative medicine 
Different biofabrication approaches have been applied to the development of 
several types of tissue and organs by using different cell types and different types of 
1 mm
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natural or synthetic derived hydrogels. Generated constructs hold promises to 
create tissue constructs mimicking many tissues and organs such as liver 68, heart 69, 
bone 70, skin 71, neurons 72, and vascular systems 73. Fig. 9 demonstrates the scheme 
of cell encapsulation for tissue engineering applications. Moreover, biofabrication 
of 3D cell-laden tissue replicates at the microscale represent a powerful tool to study 
the mechanism of cell aggregate fusion and tissue morphogenesis and can provide 
a method for high-throughput screening of cell-biomaterial interaction 24. 
 
Figure 9. Schematic diagram of cell encapsulation for tissue engineering and cell 
therapy applications. Different cell types from xeno or allo species or stem cells can 
be encapsulated and scaled up in order to manufacture functional constructs that are 
implanted into the body and used to replace or support the function of failed organs. 
Adapted from 74. 
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1.6.2 Biofabrication of tissue/organ models for drug discovery and 
toxicological screening 
Improving the ability to predict the efficacy and toxicity of drug candidates 
earlier in the drug discovery process will speed up the translation of new drugs into 
clinics 75. 3D engineered hydrogel matrices allow cell-cell and cell-ECM interactions 
and microarchitecture similar to native tissue and consequently show a similar 
response to drug compounds. Allowing rapid identification of potential candidates 
or substances toxic to human tissues has the potential to reduce the cost and time 
during the optimization stage of drug development 76. Hence, biofabricated tissues 
can provide a valuable step in the development process of drugs by allowing the 
testing and high-throughput screening of new and promising chemicals on 
functional human tissue in vitro 38,75. Moreover, the engineering of realistic tissue 
constructs will help in furthering understanding of tissue physiology and function 
and lead to the development of refined TE strategies 16,24. 
1.6.3 In vitro diseases/tumor models 
In vitro 3d constructs based on hydrogels laden with human cancer cells have 
been developed in order to reproduce and mimic the physiological environment of 
human cancer tissue 16,77. Advanced in biofabrication offer the opportunity to 
manufacture complex structures with simulated pathophysiological 
microenvironment making the disease pathogenesis process studies more relevant 
in vitro. These tumor models could thus be beneficial in cancer research to 
investigate cancer pathology, growth and metastasis thus avoiding the early stages 
of clinical trials 24,53,77. Moreover, maufactured tissue-like constructs offer the 
opportunity to reproduce accurately 3D in vitro microstructures with applications 
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ranging from cell behavior studies to improving the understanding of brain injuries 
and neurodegenerative diseases 30. 
1.6.4 Hydrogels with drug delivery capabilities. 
Hydrogels can also be used as vehicles to deliver drugs, growth factors or cell 
therapies because they are hydrophilic, biocompatible, and their drug release rate 
can be controlled and triggered by interactions with biomolecular stimuli. In fact, 
cells for which a donor shortage exists and that are unable to grow in artificial 
media, must be provided from xeno- or allo- species 74. Cell encapsulation based on 
microscale platforms, in particular beads, fibers and films, permit the diffusion of 
gas, nutrients, wastes and therapeutic products in situ once implanted 78. Many 
types of cells, including pancreatic islets cells 79, neurons or neuron-like cells 80, and 
osteoblast cells that produce human vascular endothelial growth factors (VEGFs) 81 
have been successfully encapsulated to achieve certain therapeutic purposes 74. 
1.7 Current limitations and future directions 
Encapsulation of cell in hydrogel and the creation of functional living tissues 
in the laboratory holds great promises for different tissue engineering applications. 
However, several crucial problems deserve attention before these methods may be 
implemented in clinical applications. 
The first issue is related to the material selection which remains a major 
concern and limitation for generating building blocks or to use as bioink for tissue 
engineering and regenerative medicine 23. In fact, one of the major milestones in 
biofabrication is to manufacture constructs able to mimic the cellular 
microenvironments from molecular to macroscopic scales in a hierarchical 
organized manner 38. Current fabrication and deposition techniques allow 
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researchers to design and build structures with increasingly complex architectures 
using hydrogels as building units but many concessions have been made to the 
detriment of the biological composition of the polymers. In fact, increased polymer 
concentration, unphysiological mechanical and rheological properties, toxicity of 
degradation products, non-native cell density and the lack of specific ECM proteins 
for particular cell types may limit the biological relevance of cell-laden hydrogels 39. 
The progress in the field of biofabrication and its translation towards clinical 
application are hampered by the overall lack of suitable bioinks for the generation 
of larger 3D constructs that recapitulate the heterocellular organization of the tissue 
microstructure 37. Although multiple cell types in hydrogels can migrate and 
proliferate to some extent, the majority of the currently used bioinks in 
biofabrication are biomaterials with adherent properties for cell attachment 56. In 
particular, the lack of environment for promoting differentiation and growth of 
stem cells into multiple lineages represent one of the major limitations in currently 
available hydrogel-based bioinks 82. 
The development of unique bioinks, taking into account the required 
biological competence, the physical requirements dictated by the biofabrication 
process and the degradation concerns still remains a challenge for polymer chemists 
and material scientists, as well as the relative toxicity of crosslinking 37. A solution 
to this problem could be represented by tunable bioinks with a wide range of 
material properties, for example new composite mixtures to enhance crosslinking, 
bioactivity, and other desirable features while maintaining the properties of the base 
bioinks 23. In general, highly novel hydrogels should be engineered and developed 
considering the following requirements, as reported in a recently published review 
by Ozbolat and colleagues: promotion of cell adhesion, proliferation, aggregation 
and differentiation toward multiple lineages; exhibition of high mechanical 
integrity and structural stability without dissolving after gel formation; facilitation 
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of engraftment with the endogenous tissue without generating immune response; 
high bioprintability or encapsulation-capacity with rapid solidification and ease of 
handling during post-processing; and being affordable, abundant and 
commercially available with appropriate regulatory guidelines for clinical use 56. 
Another major concern of current tissue engineering approaches is the 
inability to adequately vascularize tissues in vitro or in vivo. Issues of nutrient 
perfusion and mass transport limitations, especially oxygen diffusion, restrict 
construct development to smaller than clinically relevant dimensions and limit the 
ability for in vivo integration 73. Therefore, it becomes organic to expect that 
bioprinting can provide a viable solution for the vascularization problem and 
facilitate the clinical translation of tissue engineered constructs. Biofabrication of 
living tissues and organs at the clinically-relevant volumes vitally depends on the 
integration of vascular networks. Despite the great progress in biofabrication 
approaches, building a perusable hierarchical vascular network remains a major 
challenge. In fact, small-scale manufactured building blocks can survive through 
diffusion alone, but full-scale organs and larger tissue constructs will require an 
embedded vasculature system as well as mechanically robust conduits to connect to 
host arteries and veins 23. There is much interest in the field as researchers have 
undertaken a variety of approaches to vascularization, including material 
functionalization, scaffold design, microfluidic techniques, bioreactor 
development, endothelial cell seeding, modular assembly, and in vivo systems 83. 
Biofabrication of living tissues and organs at the clinically-relevant volumes vitally 
depends on the integration of vascular networks 73. 
Although microscale cellular encapsulation approaches enable the precise 
control over cell size and shape, mass production via cost-effective and labor-
efficient methods remains a great challenge. The scale-up of microtechnology-
based production systems into biological-relevant size constructs and the 
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automation for the production of well-controlled encapsulation products represent 
critical issues. In fact, building blocks preparation for biofabrication application can 
take several days to weeks due to cell culturing and biomaterial synthesis and this 
working time may become an issue 23. These problems may be address by 
combining large number of microwell-based bioreactors using an automation 
system. However, in order to translate these methods into a clinical-relevant supply 
chain, the integration of biofabrication methods with biopreservation strategies is 
required in order to maintain a stock of partially manufactured constructs ready to 
be used on-demand. In fact, the long-term storage and transportation of a large 
stock of building blocks represent a critical issue for the practical use of 
encapsulated cells in the form of building blocks for biofabrication or as drug-
delivery devices 74. This issue is still under discussion and based on the selected cell 
source (only autologous or also allogeneic), business model (centralized or 
decentralized) and manufacturing system (integrated or separated robotic systems) 
84. 
Biofabrication has become a strong fabrication technique to create complex 
micro- and macro-scale biomedical systems by assembling or dispensing cell-laden 
hydrogels. Nevertheless, the manufacturing of functional organs at clinically 
relevant dimensions is still impossible at the moment because there are several 
challenges such as but not limited to organization of the heterocellular nature of the 
tissue microstructure, integration of the vascular network from arteries and veins 
down to capillaries, incorporation of various cell types to recapitulate complex 
organ biology, limited structural and mechanical integrity and functionality, and 
poor long-term storage strategies for biological-relevant constructs 53. However, 
recently developed 3D biofabrication techniques provide multiple approaches for 
biofabrication or assembling of tissue constructs to solve these issues. In particular, 
the cooperation of advanced technologies that engineer 3D cell micro-
 28 
environment, such as microfluidic systems 76,85, biopatterning 86, layer-by-layer 
assembly 76,87 and biomanufacturing of micro-tissue constructs within scaffolds or 
scaffold-free environments hold promise to facilitate the fabrication of artificial 
tissues (fig. 10). 
 
Figure 10. Schematic principle of the layer-by-layer assembly of complex meso- or 
macroscale tissue constructs. The different layers can be manufactured by using 
different biofabrication techniques, such as bioprinting or cell microencapsulation, 
and hydrogels are used in order to provide mechanical integrity and recapitulate the 
cell-type-specific ECM during the process. These complex tissues feature 
micropatterns of cells (e.g. mesenchymal stem cells (MSC)), biochemical cues (e.g. 
growth factors (GF)), physical cues (e.g. stiffness gradients), and defined shapes (e.g. 
holes). Holes can be processed to favor fluid diffusion through the structure and 
could also be endothelialized. Adapted from 17. 
Although the described techniques are still in their infancy, the integration of 
cells and biomaterials through multiscale assembly strategies of building blocks or 
3D bioprinting technologies offer great potential for the production of realistic 
tissue and organ models 38,88,89. Therefore, the interaction and collaboration of 
researchers from various disciplines are needed to overcome several challenges 
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before these technologies will improve rapid clinical solutions and advance medical 
implants 16,23.  
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Chapter 2.  
Alginate Hydrogels as 3D 
Cell Culture Matrices 
A wide variety of hydrogels have been experimented within biofabrication, 
both for encapsulating cell into building blocks or as bioink for bioprinting 
applications 56. Cell-laden hydrogel formulations utilize natural hydrogels such as 
alginate, agarose, chitosan, collagen, gelatin, fibroin, and hyaluronic acid (HA), as 
well as synthetic hydrogels such as pluronic (poloxamer) and poly(ethylene glycol) 
(PEG), or blends of both. Natural hydrogels, derived from polysaccharide or 
proteins, offer inherent bioactivity, except for agarose and alginate, and display a 
chemical and structural resemblance to ECM 36,90. Several reviews papers have been 
published about hydrogels used for tissue engineering and for detailed information 
about a wide variety of materials the reader is referred to the paper of Gasperini 5, 
Ahmed 91, Peppas 6. Alginate, being the most important material of this work, will 
be described in detail with respect to its chemical content, crosslinking behavior, 
biocompatibility, manufacturing capacity and possible modifications in the present 
chapter. 
2.1 Introduction 
Sodium alginate, or alginate, is a naturally occurring polysaccharide derived 
from brown seaweeds. Microbeads obtained by gelation of a sodium alginate 
solution were used for the first time in the 1980s to encapsulate pancreatic islets and 
are currently used for encapsulating different cell types and therapeutic agents 92,93. 
Alginate is the material of choice for many cell encapsulation applications because 
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of its proven cytocompatibility, rapid ionic gelation property with divalent cation, 
hydrophilic nature, and tunable properties. It has been used as a biomaterial in 
clinic for different applications, such as wound healing, bone graft substitute for 
spine fusion, and cell therapy 8,93. 
2.2 Alginate structure and chemistry 
Commercially available alginates can be extracted from algae by using 
aqueous alkali solutions. After filtration, the alginate is precipitated into a salt with 
either sodium or calcium chloride and transformed into alginic acid by treatment 
with diluted HCl. The alginate salt is then transformed into water-soluble sodium 
alginate powder after a series of purifications and conversions 90,94,95. A more 
detailed schematic of the alginate extraction procedure is represented in fig. 11. 
 
Figure 11. Schematic showing alginate extraction procedure from algae. As a first 
step in the extraction process, the counterions are removed by proton exchange 
using 0.1-0.2 M mineral acid. Subsequently, alkali such as sodium carbonate or 
sodium hydroxide are used to neutralize the insoluble alginic acid to form sodium 
alginate. In order to remove particulate matter, rigorous separation processes such 
as sifting, flotation, centrifugation and filtration are then performed. Subsequently, 
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Sodium alginate is precipitated directly by alcohol, calcium chloride or mineral acids. 
The product is then dried and milled. Ultrapure and amitogenic alginates that are 
suitable for biomedical purposes have been produced using more rigorous extraction 
processes and purification procedures. Adapted from 95. 
Alginates are linear polymers consisting of 1,4 linked residues of ß-D-
mannuronic acid (M) and α-L-guluronic acid (G) (fig. 12) and, depending on the 
derivative algae species, polymer segments can be formed by block of consecutive 
monomers (-GGG- or -MMM-) or by alternative residues (-GMGM-) 96. The ratio 
between G and M blocks influences the mechanical properties of the alginate 
hydrogel as the G block provides structural rigidity to the polymeric structure 5. In 
general, gel elasticity, porosity and stability are increased by increasing the 
molecular weight, G-content G-blocks length 96. 
 
Figure 12. The chemical structure of alginate shown as segment of –MMGG- 
residues. Adapted from 96. 
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The alginate hydrogel derives from a water-based solution of sodium alginate. 
Viscosity of the water solution and solubility of the sodium alginate depend on the 
solution pH: at physiological condition, alginate is soluble and has an extended 
random coil conformation and when the pH is lowered, the chains form hydrogen 
bonds, producing a highly viscous solution. If the solution is too acid, a gelatinous 
precipitate of alginic acid will forms 96. 
2.2.1 Alginate hydrogels 
The gelation of sodium alginate solution can occur via two different 
processes: ionic or covalent cross-linking. The ionic gelation occurs in presence of 
divalent cations such as Ca2+, Sr2+and Ba2+. When they are added to a water-based 
sodium alginate solution, they bind two adjacent residues allowing the formation 
of ionic interchain bridges that cause a fast sol-gel transition. The formation of an 
intermolecular gel network is compatible with the survival of cells that will be evenly 
distributed throughout the hydrogel if suspended in the alginate solution prior to 
gelation (fig. 13b) 95,96. 
The amount and the type of the gel-forming ions and the gelling conditions, 
such as temperature, also affect the network structure and permeability. In fact, the 
alginate gel is characterized by a wide pore size distribution and its porosity is 
strongly influenced by the nature and concentration of gelling ions 90,96. 
Once the gel is formed, it can be dissolved by the exchange of ions with a 
buffer (e.g. phosphate buffer saline without calcium) or by treatment with a 
chelating agent for divalent cations such as ethylendiaminetetraacetic acid (EDTA) 
or sodium citrate. This can be useful to gently release cells entrapped in alginate 
hydrogels for further downstream processing 96. On the other side, because these 
gels can be dissolved due to release of divalent cations into the surrounding media, 
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a critical drawback of ionically cross-linked alginate gels is the limited long-term 
stability in physiological condition. 
 
Figure 13. (A) Interaction between gel-forming ion and four resides from two 
different chain segments. (B) Intermolecular network of alginate-polymers in 
presence of Ca2+ ions. (C) Gelling ions organized in alternative junction zone. 
Adapted from 96. 
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As a less popular alternative to ionic crosslinking, covalently cross-linked 
hydrogels can be prepared from chemically modified sodium alginate. Different 
diamines and dihydrazides have been used to covalently crosslink alginate, and 
photo-crosslinkable hydrogels can be obtained in presence of a photoinitiator and 
UV light after conjugating methacrylate groups onto the alginate backbone. 
Covalent crosslinked hydrogels allow better control over the physical properties 
and provides better chemical stability. However, covalent cross-linking reagents 
may be toxic and the process is not as easily reversible as in the case of ionic gelation 
95,96. 
2.3 Therapeutic application of cell-laden alginate hydrogels 
Pancreatic islets were the first cells immobilized in calcium alginate matrices 
by Lim and Sun at the end of the 1970s in order to treat diabetes 92. From that time, 
several approaches and adaptations of mammalian cell culture have utilized alginate 
gels as a model system in biomedical studies and for manufacturing cell therapy 
constructs 8,78. Alginate gels can be adapted to serve as either 2d or 3d culture 
systems, being the latter more relevant from a physiological standpoint. Alginate 
gels may serve as an ideal blank slate, due to the low protein adsorption and lack of 
mammalian cell receptors for alginate. The limited inherent cell adhesion and 
cellular interaction can be an advantage for cell encapsulation applications, but can 
limit the use of cell-laden constructs for tissue engineering applications 97,98. 
Different biochemical modifications can be used to adapt alginate matrix to guide 
adhesion and function of specific cells and will be discussed later. The use of 
alginate hydrogels for the realization of scaffolds and cellular constructs as an 
alternative to cell culture in 2d include the formation of beads, fibers, membranes, 
meshes, foams and other hydrogel structures that can serve as building blocks 
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according to the biofabrication paradigm 96,99. The role of alginate in pharmaceutics 
and biomedical engineering includes also different applications. Alginate is a 
commonly used polymer for sustained and localized drug delivery applications, and 
different binding and gelation mechanism allow to tune the sequence and rate of 
release 100. In the form of sponges, hydrogels and electrospun mats, alginate-based 
wound dressing have been used as substrates for the treatment of acute and chronic 
wounds, as they offer many advantages including hemostatic capability and gel-
forming ability upon adsorption 94. 
Encapsulation in alginate hydrogels has shown to be an ease, non-toxic and 
versatile method for immobilization of cells and many studies describe the use of 
this technique for treating different diseases comprehending liver failure 101, 
Parkinson’s disease 102, anemia 41, brain tumors 103, cartilage 104 and bone 105 injuries. 
In this process, living cells are suspended in alginate and the mixed solution is then 
dripped or extruded into a bath containing calcium chloride or other ions that cause 
gelation. Since the ionic cross-linking reaction is instantaneous, the cells remain 
entrapped inside the solid hydrogel matrix. Oxygen and nutrients can diffuse into 
the gel, and cells products can diffuse outside the matrix. However, the hydrogel 
represents a barrier to antibodies and immune cells, and implantation studies into 
animals and diabetic patients have demonstrated long term functionality of alginate 
hydrogel constructs containing cells 93. Therefore, cell-laden alginate hydrogel 
constructs can be implanted into animals or humans and serve as ‘biofactory’ for 
the continuous production of proteins or therapeutic agents as, for example, insulin 
8,93. Alginate hydrogels have been also broadly used for the sustained and localized 
delivery of encapsulated drugs or growth factor by controlled release from the 
crosslinked matrix. Growth factor can promote or impede cell migration, 
differentiation and proliferation and they can be combined and delivered from the 
hydrogel by exploiting different mechanisms, which allows tuning the sequence and 
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rate of release 98. As an example, Li and colleagues investigated the release of 
vascular endothelial growth factor (VEGF), a potent angiogenic molecule, from 
poly-l-lysine-coated VEGF/alginate microspheres for promoting the 
vascularization of tissue-engineered bone graft 106. 
2.4 Alginate-based encapsulating systems 
2.4.1 Alginate microbeads 
One of the most studied support for alginate cell encapsulation are 
microbeads (figure 1), that can be produced through electro hydrodynamic process. 
In this process, an electrostatic potential is applied to a needle and use to deposit 
alginate droplets in the coagulation bath where gelation occurs 27. Cells 
encapsulated with this technique remain viable inside the beads and are able to 
proliferate once released from the matrix, as demonstrated in the work of 
Liaudanskaya et al. 107 (fig. 14).  
 
Figure 14. Alginate beads created by means of electro hydrodynamic method. (A) 
Optical microscopy of B50 cells encapsulated in 2% alginate (B) Confocal 
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LIVE/DEAD assay of B50 encapsulated cells. Beads diameter equals to 200 µm. 
Adapted from 27. 
Others techniques that can be used to encapsulate cells in alginate beads 
include coaxial air or liquid flow 108, the use of micromolding platform 109, 
microfluidic-based emulsification 110 and the use of superhydrophobic substrates 44. 
Alginate has been used for encapsulating pancreatic islets since it provides some 
advantages over other system. It does not interfere with cellular functions, 
encapsulation can be done at physiological conditions and it can facilitate the 
functional survival of the islets when enveloped in microcapsules before long-term 
tissue culture 40. 
2.4.2 Alginate microfibers 
Cell-laden microfibers are recognized as another appropriate form of 
building blocks for assembling cell-laden constructs in vitro because many 
important human tissue and organs are composed of fiber-based or network-like 
structures 29,34. Meter long cell-laden fibers can be formed starting from a solution 
of alginate containing cells using techniques like electro-spinning, wetspinning, 
microfluidic spinning, interfacial complexation and meltispinning 29,34. In addition 
to cell-encapsulating structures, microfibers can also function as support for cell 
seeding and thus represent a versatile framework 111,112. The use of cell-laden fibers 
allows the use of textile technologies for making fabrics and cell-laden structures 
with precise control over the distribution of different cell types and anisotropic 
mechanical properties within the constructs. In fact, these fibers can be further 
assembled by weaving, knitting and reeling into macroscopic cellular structures 
with various spatial patterns and used as templates for the reconstruction of fiber-
shaped functional tissues that mimic muscle fibers, blood vessels or nerve networks 
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in vivo 29,111. Alginate is the most frequently used material for manufacturing cell-
laden microfibers thanks to its easy handling properties and because the 
prepolymer solution, the gelation agent and the coagulation bath are all compatible 
with living cells. Alginate-based microfibers can be easily formed with wetspinning 
method, extruding the pre-gel solution containing cells into a gelator solution 
where it continuously polymerizes by using a syringe needle or micronoozle array. 
As an example, Lee and colleagues reported the successful encapsulation of cells 
within alginate and alginate-chitosan fibers using a wetspinning microfluidic chip 
113. Nevertheless, since cells cannot adhere on the surface of the alginate hydrogel 
due to its biological inertia, alginate-based microfibers are typically employed as 
cell-encapsulating building blocks. In addition, alginate-based microfibers with 
cell-adhesive materials have been fabricated in order to improve cell adhesion. For 
example, Onoe et al. developed a double-coaxial laminar flow microfluidic device 
to create meter-long functional microfibers with a mixture of extracellular matrix 
proteins and cells as the core and alginate hydrogel as the shell 28 (fig. 15a-c). Akbari 
and colleagues reported the use of alginate hydrogels containing cells as coatings 
for synthetic polymer cores in order to create composite living fibers, subsequently 
assembled using regular textile processes 114 (fig. 15h-i). Alginate microfibers found 
also application for treating various diseases. In the work of Jue et al., primary 
pancreatic islets and hepatocytes in the form of hybrid spheroids were encapsulated 
in collagen-alginate composite microfibers using a microfluidic chip (fig 15d-g). 
The xenogenic transplantation of these constructs in vivo showed great promises 
for treating end-stage liver diseases 79. 
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Figure 15. cells encapsulated in alginate-based fibers. (a-c) Cell-containing ECM-
protein/Ca-alginate core–shell hydrogel microfibers generated with a double coaxial 
microfluidic device (adapted from 28) (d-f) A PDMS-based microfluidic chip for 
three-dimensional co-cultured hybrid spheroids composed of primary islets and 
hepatocytes in alginate microfibers (adapted from 79) (h-i) alginate-coated threads: 
(h) a non-absorbable monofilament suturing thread coated with HEK293 cell-laden 
hydrogel; (i) two-layer coating of endothelial cells (green) and preosteoblasts (red) 
on a braided suturing thread (adapted from 114). 
2.4.3 Alginate hydrogels as bioinks for bioprinting 
Alginate hydrogels are also widely used as a bioink for bioprinting 
applications, due to their compatibility with cells, fast gelation rate and the ability 
to control biodegradation (fig. 16). In fact, alginate is reasonably easy to print, as it 
is easy to process and extrude while protecting the encapsulated cells 96,99. Moreover, 
using alginate it is possible to create long-term persistent cell-laden structures, 
whereas the slow degradation kinetics of the hydrogel can be tuned by oxidation or 
by modifying the molecular weight distribution of the polymer itself. Alginate 
hydrogels possess shear thinning properties and, therefore, their viscosity is 
dependent on the strain rate. The viscosity of alginate is concentration-dependent 
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and, generally, lower concentrations of alginate are recommended for high cell 
viability 99,115. However, low concentration alginate exhibits poor mechanical 
properties and cannot be used for achieving good resolution in printing 
applications. Many attempts to optimize the resolution of alginate bioinks have 
been reported, including optimization of alginate concentration, incorporation of 
high molecular weight polymers and different hydrogel fabrication methods 52,115. 
 
Figure 16. Alginate-based bioink composed of the alginate hydrogel, cells, functional 
peptides or biomolecules to enhance the biological function of the cells, and other 
polymers forming the hydrogel to tune specific mechanical or structural properties. 
Adapted from 99. 
Different bioprinting approaches can be used for integrating living cells into 
three-dimensional alginate hydrogels, and these methods can be classified into 
three main categories as reported in cap. 1, par. 5. Extrusion-based bioprinting 
(EBB) performed with the use of a piston or a screw or other pneumatic method; 
inkjet-based bioprinting (IBB), performed by a piezoelectric actuator or a heater 
that creates bubbles; laser-assisted bioprinting (LAB), performed by a laser pulse 
that discharges bioink droplets from a donor slide onto an energy adsorbing layer 
51,73. In case of laser assisted methods, the processes involve high temperature and 
high energy radiations which make them unsuitable for bioprinting of cell laden 
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constructs 115. Therefore, extrusion and inkjet printing are the two major 
technologies which can be used for printing cell-laden constructs under 
physiological conditions. Inkjet-based methods have been used for printing 3D cell-
laden constructs due to the ability to provide good cell viability (around 90%). On 
the other side, the employed bioinks must be less viscous in comparison to 
extrusion printing and cell density also must be lower. For these reasons, the most 
employed printing solution for alginate-based bioinks relies on the extrusion 
process, since it provides a platform to print cell-laden constructs efficiently and in 
a controllable manner compatible with cell survival 115. 
In EBB methods, cells are blended with a hydrogel and loaded into sterilized 
syringes. The cell-laden hydrogel or cell spheroids are then dispensed by air 
pressure or a motorized plunger through a micronoozle onto the substrate 
according to a customized design. Different EBB systems have been experimented 
for printing living cells onto target-specific positions while encapsulating them in 
alginate hydrogel. In a recently published review, Ozbolat and coauthors reported 
a summary of these mechanism that are (i) bioplotting, (ii) bioprinting hydrogel 
with a secondary nozzle using crosslinker deposition or a spraying system, (iii) 
bioprinting using a coaxial nozzle-assisted system, (iv) bioprinting pre-crosslinked 
alginate and further crosslinking it thereafter and (v) bioprinting alginate with an 
aerosol cross-linking process 52. There are many reports detailing various extrusion-
based 3D tissue-printing systems and the parameters requested for an efficient 
printing, like printing speed, dispensing pressure and movement distance. As an 
example, Gasperini et al presented a bioprinting technique that exploits the 
electrohydrodynamic process to create a jet of liquid alginate beads containing cells 
116. The beads were placed at predefined positions and crosslinked on a gelation 
substrate thus manufacturing a cell laden hydrogel scaffold block-by-block with the 
aid of a computer deposition system. Tabriz and colleagues developed a new 
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extrusion-based bioprinting technique to produce complex alginate hydrogel 
structures by dividing alginate hydrogel cross-linking process into three steps 117. 
Each step corresponded to an increase in crosslinking level of the hydrogel. With 
this technique they were able to successfully print complex 3D constructs in the 
shape of branched vascular structures (fig. 17). 
 
Figure 17. Schematic drawing of an alginate hydrogel 3D printing setup. (a) Layers 
of partially cross-linked alginate hydrogel were printed layer by layer on the porous 
membrane and at the same time the Z axis was lowered down and the hydrogel were 
submerged into the CaCl2 bath (b) The interface layers: upward diffusion of Ca2+ 
ions into the interface layers which are partially cross-linked above the CaCl2 
solution. (c) A branched vascular structure. Adapted from 117. 
2.5 Modification of alginate hydrogels 
Although alginate is extremely cytocompatible, due to its highly hydrophilic 
nature proteins are minimally adsorbed thus hampering cell attachment on this 
material. Moreover, despite the intrinsic properties of alginate that make it a 
favorable material for tissue engineering applications, chemical modifications are 
often required to promote desirable cellular functions, provide a greater range of 
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mechanical properties, and facilitate controlled release of encapsulated factors. In 
order to overcome its limitations, alginate can be modified by covalently grafting 
extracellular matrix peptides to provide molecule binding sites for cell adhesion, 
like the RGD (arginine-glycine-aspartate) motif found in collagen or the REDV 
(arginine-glutamate-aspartate-valine) peptides found in fibronectin 49,81,118. Another 
strategy consists in mixing alginate with protein-based cell adhesive components 
such as collagen 119, gelatin 81, keratin 120 or silk fibroin 121 in order to obtain hybrid 
hydrogels with improved biocompatibility and enhanced degradation rate. These 
proteins contain cellular binding motifs, which support cellular attachment in a 
manner similar to the extra cellular matrix (ECM). Different approaches have been 
proposed in this regard: 
• In their well-known paper from 1999, Rowley and colleagues 
covalently modified alginate polysaccharides with RGD-containing cell adhesion 
ligands utilizing aqueous carbodiimide chemistry 118. Mouse skeletal myoblasts 
were cultured on the obtained alginate hydrogel surface, where they proliferated 
and differentiated towards skeletal muscle lineage. The suitability of alginate as an 
ideal material with which to confer specific cellular interactive properties was thus 
demonstrated. 
• Singh et al. compared the growth of vascular cells on different 
hydrogels substrates containing alginate (2%, wt/vol) blended with solutions of 
different proteins (silk fibroin, gelatin, keratin, or elastin at 1%, wt/vol) 122. The 
analysis of cell proliferation, metabolic activity and colonization was carried out in 
2D and the most promising results were obtained with silk fibroin- and keratin-
containing hydrogels, which supported the growth of all types of vascular cells. 
• Bocaccini and colleagues published several papers regarding alginate 
modification for enhancing its biocompatibility by resembling the mechanical, 
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structural and chemical properties of the native extracellular matrix. In their works, 
they developed modified alginate hydrogels in which cell adhesive functionality 
were conferred by blending with gelatin 97, silk fibroin 123 and keratin 120. They used 
this hybrid material to fabricate hydrogel films and hydrogel microcapsules. Cells 
were either seeded onto prefabricated hydrogel substrates (2D) or encapsulated 
during hydrogel microcapsules formation obtained with pressure-driven extrusion 
technique (3D). Their results indicated that such novel hybrid hydrogels supported 
cell attachment, spreading and proliferation and thus represent promising materials 
for biomedical applications in tissue-engineering and regeneration. As an example, 
the presence of silk fibroin in the blend makes the gel stiffer compared with pure 
alginate, and improve the physical-chemical properties in both the geometries of 
the blend 123. As far as cell-interaction is concerned, they showed that silk fibroin 
provides anchorage and a growth-supporting environment for both cells seeded on 
the films and for cells encapsulated in the microcapsule compared with structure of 
pure alginate 123. However, they did not compare the behavior of cells processed 
with the different hydrogel systems. 
• Cell-sheet culture substrates were developed by Yan and coworkers 
using the ability of calcium alginate hydrogels to be dissolved under mild conditions 
49. The alginate was modified by conjugating the integrin binding peptide sequence 
RGD to the alginate solution in order to confer cell attachment sites to the hydrogel. 
The modified alginate hydrogel supported the attachment and growth of fibroblast 
and human corneal epithelial cells (HCECs) sheets, subsequently detached from the 
substrate through chelating the calcium using citrate. The cell–cell connections 
were retained following this release and the cell layers adhered to each other and 
grew after being stacked. 
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2.6 Challenges and future directions 
A major disadvantage of alginate bioinks is the formation of relatively soft 
gels at lower concentrations, even after crosslinking. On the other hand, high 
concentration gels possess high stiffness and low diffusion properties, thus 
hampering cell proliferation and functionality. Therefore, it is challenging to print 
multilayered structures which can recapitulate the complexity of tissue-like 
structures 115. In this framework, modular approaches would confer the ability to 
scale up by assembling layer by layer building blocks to create macroscopic tissue 
constructs. 
The size of the hydrogel constructs is another critical parameter for 
biomedical application of encapsulated cells. The bead, fiber or printed bioinks 
must be large enough to contain the biological material and larger constructs are 
also easier to handle during washing or further assembling processes. However, the 
absence of convection movement within a capsule induces an oxygen- and nutrient-
gradient from the surface to the construct resulting in necrosis of the inner cells 124. 
In fact, although the nanoscale porosity of alginate gel permits the diffusion of 
solutes through its network, this process is limited when the size increases. A study 
published by Gasperini et al. identified the critical diffusion distance of 400 µm for 
2% (wt/vol) alginate containing 5 M cells/mL for effective oxygen and nutrient 
transfer to cells at interior positions 27. Specific types of geometry can be design in 
order to balance the critical issues regarding the size of an alginate-based cell culture 
system. 
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Chapter 3.  
Effect of Cryopreservation on Cell-Laden 
Hydrogels: Comparison of Different 
Cryoprotectants 
An important issue for the clinical implementation of cell encapsulation and 
biofabrication techniques is the long-term storage of a large stock of cell/hydrogel 
building blocks. In this chapter, the impact of cryopreservation on the viability and 
functionality of cells encapsulated in alginate matrices is presented comparing 
different cryoprotective agents (CPAs). Human osteosarcoma MG63 cells were 
encapsulated in sodium alginate fiber constructs with wetspinning method and 
exposed to different formulations of cryopreservation media, containing dimethyl 
sulfoxide (DMSO), glycerol, and trehalose. The cell-laden fibers were subsequently 
slow-cooled down to -80°C and stored in liquid nitrogen. After thawing, viability 
and death pathway of encapsulated cells were investigated, and metabolic activity 
and proliferative capacity of cells released from the alginate matrix were evaluated. 
The viability of MG63 cells encapsulated in alginate matrix ranged from 71%±4% 
to 85%±2%, depending on the cryoprotective media formulation with no protracted 
harmful effects from the CPAs. On the other side, cells cryopreserved in 
encapsulated conditions and released from the hydrogel showed larger metabolic 
activity and proliferative capacity in tissue culture plate compared to cells 
cryopreserved in suspension, in particular when DMSO and glycerol were used as 
CPAs. Results have been correlated with the viscoelastic properties and water 
content changes of the alginate constructs loaded with the different CPAs. 
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3.1 Introduction 
3.1.1 The principle of cryopreservation 
Given recent advantages in the field of biofabrication and bioprinting, the 
tissue engineering community is becoming increasingly concerned with the 
problems of bringing manufactured tissue constructs into the clinic and into the 
market 125. One major obstacle for the successful clinical and commercial 
application of emerging cell-based technologies is the development of effective 
preservation and long-term storage techniques for encapsulated cells. The challenge 
of maintaining large stock of cell-laden building blocks and bioinks in order to 
ensure a steady supply will make necessary the creation of banks to meet the 
unpredictable demand for specific cell-laden constructs in clinical, industrial and 
scientific research settings 125,126. Manufacturers and/or distributors thus aim to 
develop technique that (1) preserve the viability and functionality of encapsulated 
cells and (2) maintain the integrity of the living constructs or engineered tissue 
surrogates 127. Simple preservation techniques, such as in vitro culture, hypothermic 
storage and desiccation have drawbacks including limited shelf-life, high costs, risk 
of contamination and negative impact on biomaterial integrity. Cryopreservation, 
an approach based on the principle that chemical and biological processes are 
effectively arrested at cryogenic temperature, represents a more adequate option 
that permits the long-term preservation of living cells, tissues and biological 
samples 125,127,128. 
According to cryopreservation principle, the beneficial effect of decreased 
temperature is used to suppress molecular motion thus arresting metabolic and 
biochemical reactions. Although temperatures below –80 °C are generally 
considered sufficient for successful preservation of cells and tissues for periods of 
time up to 6 months (according to standard protocols), as the storage temperature 
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is reduced the shelf-life increases dramatically 125. In fact, a state of “suspended 
animation” can be achieved below –150 °C as there are very few biologically 
significant reactions or changes to the physicochemical properties of the system 127. 
At –196 °C (the boiling point of liquid nitrogen) the thermal energy is insufficient 
for any chemical reaction, and the only deterioration that can occur in a biological 
sample is DNA damage by background radiation and cosmic ray 125. At liquid 
nitrogen temperature, the shelf-life of stored cells has been estimated to be of the 
order of 103 years. At the end of the cryopreservation process, cells are thawed and, 
ideally, resume biological activity 129. However, experimental findings underlined 
an apparent contradiction between the concept of preservation and damages 
occurred to living cells and biological samples due to the cryopreservation process 
itself 128. Therefore, an extremely important part of the research in fundamental 
cryobiology and tissue engineering is to reveal the underlying physical and/or 
biological mechanisms related to the injury of cells at low temperatures (namely 
cryoinjury) 128. The exact mechanism of cryoinjury has long been debated, and the 
variety of explanations reflects the fact that different cryopreservation protocols 
affect the cells in different ways 128,130. According to Pegg, freezing injury has been 
shown to have two components: direct damage from the ice crystals formation 
inside the cell; and secondary damage caused by the increase in concentration of 
solutes as progressively more ice is formed, resulting in dehydration of the cells by 
osmosis through their semipermeable membranes 131. Intracellular freezing is 
generally lethal but can be avoided by sufficiently slow cooling, and under usual 
conditions osmotic damage dominates (fig. 18). The precise events occurring to 
cells during freezing, that may be lethal for cell survival, can depend on the cell type, 
the freezing temperature, the freezing rate, and the nature of the extracellular 
solutes 128,130. 
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Figure 18. Schematic of the events occurring in cells during freezing. If freezing is 
too slow, ice formation inside the cells is avoided but cells undergoing slow freezing 
processes still suffer injuries, due to the severe volume shrinkage and long-term 
exposure to high-solute concentrations. On the opposite, if cells are cooled too 
rapidly, intracellular water is not lost fast enough to maintain equilibrium and the 
cells become increasingly supercooled, thus freezing intracellularly. If cooling rate is 
optimally balanced, cells lose water rapidly enough to concentrate the intracellular 
solutes thus avoiding supercooling. As a result, cells dehydrate and do not freeze 
internally. Adapted from 128. 
3.1.2 The role of cryoprotectants 
In order to successfully store cells and engineered tissues for extended 
periods, taking advantage of the protective effects of sub-zero temperatures, 
damage during freezing and thawing must be minimized 127. Cryoprotectants agents 
(CPAs), added during the cryopreservation process, protect cells from cryodamage 
by decreasing the freezing point at which intracellular ice forms thus minimizing 
the damage caused by cooling 89,129,130. CPAs act as osmotic buffers preventing 
harmful critical electrolyte concentration gradients and stabilize cell membranes by 
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maintaining macromolecules in their native form 129. CPAs such as dimethyl 
sulfoxide (DMSO) and glycerol can penetrate the cell membrane at physiological 
temperatures, however, their penetration ability rapidly decreases when 
temperature lowers 125,130,132. Disaccharides like trehalose, mannitol, and sucrose do 
not cross the cell membrane and act stabilizing the transmembrane proteins 127. In 
some cases, multiple types of cryoprotectants are used in association 133,134. 
Nevertheless, CPAs are generally toxic and must be removed by washing protocols 
after cells thawing 89. If sufficient cryoprotectant could be introduced to avoid 
intracellular freezing, osmotic and toxic damage caused by the required high 
concentrations of cryoprotectant may become critical problems 131. Therefore, 
optimization of cryoprotectant agent and concentration for a specific cell type and 
cooling conditions, as well as understanding the physical and biological factors 
affecting survival of cells at low temperatures, are required in order to develop 
effective techniques to protect cellular systems from cryoinjury 127,128,131. 
3.1.3 Cryopreservation of engineered tissue constructs 
A lack of understanding of the mechanisms responsible for damage of more 
complex cellular systems – cell aggregates and organized tissues and even organs – 
has limited the successful cryopreservation of cell aggregates, cell-laden hydrogel 
modules and engineered tissues used in clinical or industrial applications 127,131. 
Critical issues relevant to the application of cryopreservation methods to 
engineered tissue constructs require knowledge of the individual and combined 
contributions of the cell and matrix components to the overall response to freezing 
and thawing 127,129. There are a number of unique elements that complicate the 
cryobiology of tissue systems, including heat and mass transfer constraints of these 
bulk systems, intrinsic differences between isolated and cultured cells, and 
mechanisms of freezing injury unique to complex cellular systems 131,135. The 
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macroscopic size and defined geometry of cell-laden constructs result in restrictions 
on cooling and warming rates that can lead to spatial variations in cryoprotectant 
concentration. Moreover, the function of tissue systems depends upon the 
characteristic cell–cell and cell–matrix interactions that may act as critical targets 
for or mediators of cryoinjury. Finally, the formation of ice within the nonliving 
intercellular matrix that contains the living cells can result in excessive dehydration 
of the surrounding cellular components thus leading to significant injury. The 
combined effect is an irregular distribution of damage sites within the cell-laden 
constructs that is also affected by the presence of cryoprotectants and the growth of 
ice crystal. Therefore, the extension of cryopreservation techniques to structured 
cellular systems must consider not only the in situ cellular function, but also the 
effects that matrix structure and composition have on the low-temperature 
response of the cells 127,135. 
Several techniques have been proposed for the cryopreservation of cells 
encapsulated in different materials, tailored for specific applications such as storage 
of mesenchymal stromal cells 136, neurospheres 80, and pancreatic substitutes 137; 
preservation of tissue-engineered substitutes 138,139; and assembly of three 
dimensional constructs containing cells 138,140. A selection of these works is 
summarized in tab 1. 
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Ref. 
Cell type 
Material CPAs Assays 
Application 
136 
hMSCs 
alginate 
microcapsules 
DMSO (different 
amount) 
cell viability and 
metabolism; 
differentiation 
pathways 
tissue engineering 
140,141 
hADSCs 
gelatin/alginate 
3d grid 
constructs 
DMSO, glycerol, 
dextran-40 
(various mixture) 
cell viability, 
proliferation, and 
metabolism; 
rheological properties; 
water content 
biofabrication, 
organ 
manufacturing 
139 
hADSCs 
k-carrageenan 
hydrogel discs DMSO (10% v/v) 
cell viability and 
proliferation; 
histological analysis; 
mechanical properties 
cartilage 
regeneration 
133 
CV1 (kidney cell 
line) Collagen 
microcapsules 
DMSO, ethylene 
glycol, sucrose 
(various mixtures) 
cell viability; integrity 
of microcapsules 
- 
142 
HepG2 
alginate beads 
DMSO (12% v/v), 
University of 
Wisconsin Solution 
(UW) (38% v/v), 
cholesterol 0.1% 
wt/vol 
Cell viability; protein 
synthesis; glucose 
consumption; 
chemical assessment 
of alginate (FTIR) 
transportation of 
bioengineered 
products 
137 
C2C12 (myoblasts) 
RGD–modified 
alginate 
microcapsules 
3M DMSO, 3M 1,2-
propanediol, 0.5M 
sucrose 
cell viability and 
metabolic activity; 
bead integrity; 
secretory activity 
insulin-secreting 
pancreatic 
substitutes 
143 
hMSCs 
alginate/gelatin 
cryogel scaffold DMSO (10% v/v) 
cell viability and 
metabolism; scanning 
electron microscopy 
(SEM) analysis 
regenerative 
medicine 
134 
keratinocytes chitosan- 
gelatin 
membranes 
DMSO, trehalose 
(various mixture) 
cell viability and 
proliferation; secretory 
activity; mechanical 
properties 
tissue-engineered 
epidermal graft 
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Table 1. Summary of the samples used for the in vitro analysis associated with their 
particular fabrication steps. hMSCs (human mesenchymal stromal cells); hADSCs 
(human adipose-derived stem cells); mESCs (mouse embryonic stem cells); HepG2 
(immortalized hepatocyte cell line). Adapted from 144. 
The abovementioned studies examined peculiar properties of the proposed 
method, focusing on evaluating the viability, proliferation, and differentiation 
potential of encapsulated cells. Moreover, in certain cases the ability of the materials 
to withstand the cryopreservation in term of structural integrity and mechanical 
properties was evaluated 134,138,140. However, none of these studies has systematically 
compared the effect of different cryoprotectants. 
3.1.4 Aim of the work 
In this work, we evaluated the effect of cryopreservation and of different 
cryoprotectants on the biological recovery of human MG63 osteosarcoma cells 
encapsulated in alginate filamentous constructs, used as model cells-hydrogel 
system, made by spinning cells/water alginate solutions onto a gelling bath 
containing calcium ions 29. The aim was to optimize the alginate-cryoprotectant 
formulations and to assess the different ability of DMSO, glycerol, and trehalose to 
preserve encapsulated cells biological functions after a conventional slow freezing 
protocol 130,131. Alginate was selected as matrix because cells can be retrieved by 
dissolving the encapsulating matrix with the use of chelating agents such as EDTA 
or sodium citrate 5. Moreover, alginate does not promote cell adhesion and 
proliferation due to the absence of biorecognition motifs 96. In our case, these 
phenomena could potentially interfere with the response of encapsulated cells that 
undergoes the cryopreservation process. After thawing, the viability of cells 
encapsulated in the fibers, and their proliferation and metabolic functions recovery 
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upon dissolution of the alginate matrix were evaluated. All the results were 
compared with non-encapsulated cells cryopreserved at the same conditions. The 
effect of the freezing-thawing on the physical properties of the alginate matrix was 
evaluated with dynamic rheological tests and by measuring the liquid content of the 
material before and after freezing. The schematic of the biological experiment is 
reported in fig. 19. 
 
Figure 19. schematic of the biological experiments. MG-63 cell-laden alginate fibers 
are produced by wetspinning and equilibrated with different formulation of CPAs 
(containing DMSO, glycerol and trehalose) before slow freezing and storage in liquid 
nitrogen. After thawing the viability of encapsulated cells is evaluated up to 3 days. 
A batch of fibers is dissolved in order to release the cells and evaluate the cell viability 
DMSO glycerol trehalose
DMSO 10%  (v/v) − −
DMSO + treh 10%  (v/v) − 0.4 M
glyc − 10%  (v/v) −
glyc + treh − 10%  (v/v) 0.4 M
mixing MG63 cells with
2%  (w/v) sodium alginate
encapsulation of cells 
within fibers through 
wetspinning
equilibration with 
cryoprotectants
slow freezing at
-80°C & storage
in liquid N2
Thawing of fibers Dissolution of alginatein chelating solution
assessment of cell viability:
Live & dead staining and
confocal microscopy analysis
3 hours
24 hours
72 hours
assessment of cell death 
pathway:
apoptosis/necrosis flow
cytometric detection
3 hours
quantification of cell 
proliferation and metabolism
in TCP: alamarBlue and 
PicoGreen colorimetric 
assays)
1 day
2 days
4 days
6 days
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and death pathway immediately after thawing. Finally, a batch of released cells is 
transferred in TCP and cultured up to 6 days in order to evaluate cell recovery in 
terms of proliferation and metabolic activity. 
3.2 Materials and Methods 
3.2.1 Materials 
The following materials were used: sodium alginate powder derived from 
brown algae alginic acid, calcium chloride dihydrate, dimethyl sulfoxide (DMSO), 
glycerol, D-(+)-trehalose dihydrate, sodium citrate dihydrate, 0.05% Triton X-100 
(Sigma-Aldrich, USA); Calcein-AM, Propidium Iodide (PI), phosphate buffered 
saline (PBS), Minimum Essential Media (MEM), 200 mM L-glutamine, 100 mM 
sodium pyruvate, 100´ MEM Non-essential Amino Acids, 100´ Antibiotic-
Antimycotic solution, 0.05% Trypsin-EDTA solution, Quant-iT PicoGreen dsDNA 
Assay Kit, alamarBlue Cell Viability Assay (Invitrogen, USA); Fetal Calf Serum, 
Trypan Blue 0.4% solution (Lonza, Switzerland); MG63 osteosarcoma cell line 
(ATCC® CRL-1427™) (Istituto Zooprofilattico Sperimentale della Lombardia e 
dell’Emilia Romagna, Italy); Sonicator (UP400S Heilscher, Germany); 
Apoptotic/Necrotic Cells Detection Kit (PromoKine, USA). 
3.2.2 Hydrogel preparation and sterilization 
Alginate powder was dissolved in PBS overnight at room temperature to 
obtain a 2% wt/vol alginate solution. The crosslinking solution consisted in calcium 
chloride dihydrate dissolved in distilled water at a concentration of 200 mM. For 
sterilization, the two solutions were filtered through a 0.22-µm filter before use. 
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3.2.3 Cell culture and encapsulation 
MG63 osteosarcoma cells were thawed and expanded using standard 
protocols. In particular, cells were expanded in tissue-culture treated flasks as 
monolayer at 37°C under 5% CO2 to 85-90% confluence before encapsulation. 
Culture medium was composed of MEM containing 10% fetal bovine serum 
(GIBCO), 2mM glutamine, 1 mM sodium pyruvate, 1% non-essential amino acids 
and 1% Antibiotic Antimycotic solution. At sub-confluence cells were detached 
from the flask with the Trypsin solution. Subsequently, cells were centrifuged at 
1000 rpm for 10 minutes, rinsed in PBS to remove any residues of culture medium 
and finally dispersed by vortexing inside the buffer. An aliquot of the suspension 
was used to determine cells concentration using a hemocytometer (Sigma, USA) 
and Trypan Blue 0.4% as contrasting agent. Cells were centrifuged again and, after 
removing the supernatant, resuspended in the proper amount of alginate solution 
to obtain a suspension containing 2´106 cells/mL. 
400 microns diameter alginate fibers about 5 cm long containing cells were 
formed by wetspinning 29. The method involved extruding through a 0.5-20 µL filter 
tip (Corning, USA) 20 µL of cells/alginate solution onto a Petri dish containing the 
calcium chloride crosslinking solution. Gelation occurred instantaneously upon 
contact with the solution containing Ca2+ ions. After a few minutes, formed fibers 
were washed twice with MEM in order to remove residual calcium. 
3.2.4 Cryopreservation and thawing 
Prior to cryopreservation, cell-laden fibers were incubated at 37°C in 5% CO2 
atmosphere for 30 min in culture medium containing 20% (v/v) FBS with addition 
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of cryoprotectants (herein referred as cryopreservation media) in the amounts of 
tab. 2 following indications reported in the literature 134,145. 
 DMSO (v/v) glycerol (v/v) trehalose (M) 
No-CPAs – – – 
DMSO 10% – – 
DMSO+treh 10% – 0.4 
Glycerol – 10% – 
Glycerol+treh – 10% 0.4 
Table 2. Cryopreservation media composition. The media are prepared by adding 
the reported compounds to the culture medium. 
After incubation, they were moved to cryovials (5 fibers per vial), that were 
inserted in a commercial cooling box (Cool Cell Freezing Container, Biocision, 
USA) and cooled from +37 to −80 °C at -1°C /min. The next day, vials were 
transferred to liquid nitrogen. For in vitro evaluations, vials were fast thawed in a 
water bath at 37°C and immersed in fresh culture medium that was changed after 2 
and 4 hours in order to remove CPAs residues from the alginate matrix. Non-
encapsulated cells batches were prepared for comparison by using the same 
procedure. This method is below referred as standard cryopreservation protocol. 
3.2.5 In vitro evaluation 
In vitro evaluations were performed on encapsulated cells (live/dead assays 
and cell death pathway), on cells released from the alginate matrix and cultured on 
TCP (proliferation and metabolic activity) and on control batches. The complete 
scheme of the experiments is reported in fig. 20. 
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Figure 20. Summary of the samples used for the in vitro analysis associated with their 
particular fabrication steps. Adapted from 144. 
For cell release, fibers were incubated in a chelating solution (55 mM 
trisodium citrate, 10 mM HEPES in PBS) at 37°C for 5 min. After centrifugation at 
1000 rpm for 5 min the supernatant was removed, and the precipitate with cells was 
washed in PBS again to remove any residues of chelating solution. An aliquot of 
suspension was taken to evaluate the cells concentration using the hemocytometer 
and Trypan Blue as contrasting agent. 
Cells viability and distribution in fibers. Confocal microscopy (Nikon A1, 
Japan) was used to determine cells viability and distribution in the alginate fibers as 
prepared (no-CPAs control) and in frozen fibers after thawing, at 3h, 24h and 72h. 
A standard two-color live/dead assay was performed after incubating the fibers in a 
PBS solution containing 1 µg/mL calcein AM and 20 µg/mL Propidium Iodide for 
30 min at 37°C. Live cells are distinguished by the presence of intracellular esterase 
activity, determined by the enzymatic conversion of the nonfluorescent cell-
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permeant calcein AM to the intensely green fluorescent calcein. Dead cells fluoresce 
red since their damaged membranes are permeable to the high-affinity fluorescent 
nucleic acid stain Propidium Iodide. Confocal images were collected along the Z-
axis with 10 µm intervals (488 nm wavelength laser and 500 to 550 nm detector for 
calcein; 560 nm wavelength laser and 570 to 620 nm detector for Propidium Iodide). 
The viability of encapsulated cells was reported as the ratio of the number of alive 
cells to the total number of cells in each fluorescent image, automatically counted 
with the Fiji distribution of image processing software ImageJ 146. At least 5 fibers 
were analyzed for each group. 
Flow cytometric apoptosis/necrosis detection. Flow cytometry analysis was 
used to discriminate in control and released cell samples between apoptosis and 
necrosis pathways, the two essential processes leading to cell death, after staining 
the cells with an apoptotic/necrotic detection kit (PK-CA707-30017, PromoKine). 
Cells were incubated for 15 min in the dark in a buffer solution containing Annexin 
V-FITC and Ethidium Homodimer III. Annexin V labeled with fluorescein (FITC) 
stains with green fluorescence phosphatidylserines, which are translocated from the 
inner to the outer surface of the apoptotic cells for phagocytic recognition. 
Ethidium homodimer III binds to the nucleic acid; it is impermeant to [does not 
penetrate into] live and early apoptotic cells while staining necrotic and late 
apoptotic cells with red fluorescence. Subsequently, cells were run at low rates 
through the FACSCalibur flow cytometer (BD, Singapore) to measure optical 
transmission, side scattering and emission fluorescence at 530±30 nm and 585±42 
nm of at least 10,000 cells, upon excitation at 488 nm. Low green and low red 
fluorescence was scored as viable (low left quarter), high green and low red 
fluorescence was scored as early apoptotic (low right quarter), low green and high 
red fluorescence was scored as late apoptotic/necrotic (upper right quarter), high 
green and high red fluorescence was scored as late necrotic (upper left quarter) (fig. 
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21). Standard error was calculated considering the maximum and minimum 
number of events occurring in each of the four regions by varying the position of 
the region boundaries. 
 
Figure 21. Region classification according to Annexin V and Ethidium Homodimer 
III intensity after apoptosis/necrosis staining and flow cytometry analysis. 
Recovery of cell functionality. Upon thawing, cells were released from the 
alginate matrix as previously reported and manually counted with a 
hemocytometer. 2000 cells/cm2 were then transferred into a TCP (2k cells per well 
in a 48-well plate) (fig. 22). 
 
Figure 22. schematic of the method for releasing cells from the alginate matrix after 
thawing. After dissolving the alginate matrix in a sodium citrate-based chelating 
solution, released cells are counted and cultured in TCP. 
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The next day and for 6 days thereafter, the metabolic activity of cells was 
evaluated with alamarBlue assay, which uses the reducing power of healthy cells to 
convert resazurin to the fluorescent molecule resorufin, and the proliferation of 
cells was evaluated with PicoGreen assay, a dsDNA-intercalating fluorophore. At 1, 
2, 4 and 6 days, cells were incubated for 2 h with culture medium containing 10% 
alamarBlue and fluorescence intensity was measured on a plate reader (535±25 nm 
excitation and 590±20 nm emission; Spark 10M, Tecan, Switzerland). Subsequently, 
DNA extraction was performed by disrupting the cells membrane with a solution 
of 0.05% Triton-X in PBS, followed by sonication (UP400S, Hielscher, Germany) 
for 10 s. PicoGreen was then used for the quantification, measuring the fluorescence 
intensity of PicoGreen-DNA complex with the plate reader (485±20 nm excitation 
and 535±25 nm emission). A calibration curve was built up using the DNA standard 
provided with the assay to correlate fluorescence intensity to DNA concentration. 
Cells exposed to standard cryopreservation procedure were used as reference. For 
each test nine replicates were used. 
Statistical analysis. Graphpad Prism 7 software was used for statistical 
analysis. Results are expressed as mean ± standard deviation (SD) and significance 
was tested using two-way analysis of variance with Tukey’s post hoc test. A p value 
of 0.05 was considered significantly different. 
3.2.6 Evaluation of material properties 
Rheology. Alginate hydrogels were submitted to rheological test before and 
after freezing by using a parallel-plate rotational rheometer (Discovery HR-2, TA 
Instruments, USA) with 40 mm diameter plate. The samples were prepared by 
casting liquid alginate (as described in par. 3.2) onto gelatin molds containing 
calcium chloride until complete gelation occurred. Alginate discs (diameter 40 mm, 
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height 2 mm) were then detached from the gelatin substrate and incubated with the 
different CPAs (as described in par. 3.4) overnight to assure complete diffusion of 
the CPAs in the alginate matrix. The samples were subsequently cooled to −80°C 
before transferring into liquid nitrogen and finally thawed at 37°C. After rinsing the 
sample in DI water to remove the CPA residues, rheological properties were 
investigated. Frequency sweep experiments were conducted from 0.01 to 10 Hz at 
a fixed strain and temperature of 2% and 37°C respectively. Storage modulus (G¢) 
and loss modulus (G¢¢) were measured as a function of frequency. At least 3 samples 
were evaluated for each condition. As a control, fresh samples were tested after 
incubation with the CPAs and rinsing in DI water. 
Liquid content. The liquid content of the alginate hydrogels before and after 
freezing was investigated by weighing the samples in the wet and dry state. Alginate 
discs were fabricated as described in the previous paragraph, incubated in presence 
of the different CPAs, frozen-thawed and rinsed in DI water overnight to remove 
any CPA residues. As a control, fresh samples were tested after incubation with the 
CPAs and rinsing in DI water. Subsequently, the samples were weighted before and 
after completely drying in an oven at 65°C overnight. The liquid content of the 
hydrogels was determined by the following equation, where Mwet and Mdry represent 
the mass of the samples before and after drying. 𝐶% = 𝑀%&' −𝑀)*+𝑀%&' × 100 
At least 5 samples were evaluated for each condition. 
3.3 Results 
3.3.1 Cells distribution 
When injected in the calcium chloride bath, alginate underwent a fast sol-gel 
transition with the formation of a solid gel fiber. Fibers were left in the crosslinking 
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solution for about 10 minutes, to allow the diffusion of calcium ions towards the gel 
core. In fig. 23 a live/dead representation of an alginate fiber containing cells is 
reported. The mean diameter of the fiber, measured by optical microscopy, is 
387±98 µm (n=9), which is compatible with nutrients diffusion in presence of high 
cell densities 27. Moreover, cells appear homogeneously distributed inside the fibers. 
 
Figure 23. Representative confocal microscopy image of cells encapsulated in a wet-
spun alginate fiber stained with live/dead (green/red) fluorescent dyes. Adapted from 
144. 
3.3.2 Viability of encapsulated cells 
The effect of the different cryoprotective formulations on the viability of 
encapsulated cells was evaluated on all samples after thawing. Visualization of the 
alginate fibers containing cells by confocal microscopy, after standard Live/Dead 
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staining, was used to discriminate alive from dead cells (fig. 24 a). Cell viability was 
evaluated at 3, 24 and 72 hours after thawing. Results were compared with two 
systems: fibers loaded with cells not frozen (non-cryo) and fibers loaded with cells 
frozen in absence of cryoprotectant (no-CPAs). Images indicated limited cell death 
in any of the cryopreserved samples, less than or equal to the non-cryo control. For 
quantitative analysis, live and dead cells were automatically counted and 
discriminated using the Object Counter plugin of Fiji software 3 hours after 
thawing (fig. 24 b). Subsequent time points quantification of cell viability was not 
performed since Propidium Iodide is not able to stain cells that are dead more than 
1-2 days before, not allowing reliable cumulative count of dead cells. A decrease of 
viable cell number was observed after cryopreservation compared to non-cryo 
group (viability 91±2%). A higher retention of cell viability was observed for cells 
cryopreserved with DMSO (85±2%) compared with glycerol (71±4%), 
DMSO/trehalose (71±2%) and glycerol/trehalose (72±6%). 
3.3.3 Apoptosis/necrosis detection after thawing 
The effect of the various cryopreservation protocols on the pathway of cell 
death during freezing were analyzed by flow cytometry (fig. 25 a). Results were 
compared with non-frozen cells and with cells frozen with standard protocol. 
In general, for all cryoprotectants, cell viability was greater than control 
formulations without any cryoprotectants (no-CPAs controls) (fig. 25 b). We 
observed a decrease in cell viability for the cryopreserved encapsulated cells 
compared to the standard cryopreservation protocol both with DMSO (75.0±6.0% 
vs 60.3±4.6%) or glycerol (80.1±5.0% vs 49.5±2.8%). Furthermore, we observed a 
decrease of early apoptosis signal and a shift toward late apoptosis/necrosis signal 
for encapsulated cells. With trehalose, cell viability decreased both for standard 
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cryopreservation and for cryopreservation after encapsulation (60.3±4.6% vs. 
50.1±3.1% for DMSO and 49.5±2.8% vs. 43.7±2.2% for glycerol). This result 
confirmed the qualitative live/dead confocal analysis evaluations. 
 
Figure 24. (a) Live/dead analysis with confocal microscopy of MG63 cells 
encapsulated and frozen in alginate fibers (cross-section) with the different CPAs 
formulation and at different time points after thawing. All scale bars are 100 µm. (b) 
cell viability in the fibers analyzed with ImageJ cell counting 3 hours after thawing. 
Error bars represents mean ± SD (n=5). ***p<0.001 and ****p<0.0001. Adapted from 
144. 
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Figure 25. (a) Flow cytometric results of concurrent staining with FITC-Annexin V 
and Ethidium Homodimer III to detect apoptotic/necrotic cells after thawing (std 
and encap groups) and dissolution of the alginate matrix (encap groups); (b) 
corresponding distribution of viable, early apoptotic, late apoptotic and necrotic 
cells. Error bars represent mean ± SE, calculated on 103 gated cells. Adapted from 144. 
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3.3.4 Cell proliferation and metabolic activity 
The results of cell proliferation and metabolic function are reported in fig. 26 
and 27 respectively. Upon thawing, cells were released from the alginate matrix 
using a calcium ions chelating solution and transferred in TCP. The relative 
fluoresce intensity was normalized to the value at day one for each group. At day 
two, cells frozen with cryoprotectants showed a comparable DNA content. 
Considering the effect of encapsulation, at day 4 and 6 we observed a significant 
increase in cell proliferation in presence of DMSO (increment of 12.5±0.9 fold vs. 
15.8±1.8 fold at day 6) and glycerol (16.9±1.4 vs. 18.3±1.3 at day 6). The 
encapsulated group frozen by using DMSO/trehalose exhibited an increase of cell 
growth with respect to the DMSO alone (15.8±1.8 vs. 18.6±2.4 at day 6). On the 
contrary, when glycerol was used, the addition of trehalose led to a significant 
inhibition of cell proliferation (18.3±1.3 vs. 11.5±1.1 at day 6). 
 
Figure 26. Cell number evaluation at each time point from the various frozen groups 
after thawing. Std: cell frozen with standard protocol (1M cells/vial in 
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cryopreservation medium. Encap: cell frozen after encapsulation, following 
dissolution of the gel. Values are normalized to day 1 for each group. Error bars 
represent mean ± SD (n=9). **p<0.01 and ****p<0.0001. Adapted from 144. 
Cells metabolic activity was determined with the alamarBlue assay and data 
were normalized to the value at day one for each group. All cryopreserved cells 
exhibited an increase of metabolic activity from day 1 to 6 and confirmed the trend 
of cell proliferation signal. Considering the use of a single cryoprotectant, cells 
frozen after encapsulation exhibited a significantly increased metabolic signal from 
day 4 onward, both for DMSO (increment of 9.3±0.8 fold vs. 10.3±1.2 fold at day 6) 
and glycerol (9.9±0.8 vs 14.2±1.2 at day 6). This result matches the cell proliferation 
profile, and confirms previous results on fibroblasts-like cells cryopreserved in 
suspension and in a 3D construct 147. Regarding the effectiveness of the different 
CPAs for encapsulated cells, glycerol led to higher cell recovery 6 days after thawing. 
The addition of trehalose during cryopreservation was favorable for the metabolism 
of cells frozen after encapsulation in presence of DMSO (10.3±1.2 vs 13.1±1.4 at day 
6). Overall, encapsulated cell cryopreserved with glycerol led to the best 
performance in terms of metabolic and proliferative recovery after 
cryopreservation. 
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Figure 27. Cell metabolic activity in TCP at each time point from the various frozen 
groups. Std: cell frozen with standard protocol (1M cells/vial in cryopreservation 
medium). Encap: cell frozen after encapsulation, following dissolution of the gel. 
Values are normalized to day 1 for each group. Error bars represent mean ± SD 
(n=9). *p<0.05, **p<0.01 and ****p<0.0001. Adapted from 144. 
3.3.5 Rheological properties 
The rheological behavior of the hydrogel was analyzed in order to evaluate 
the influence of a freezing-thawing cycle on the mechanical properties of alginate. 
Frequency sweep measurements of alginate samples incubated with the different 
CPAs before freezing and after thawing were compared. In particular, storage and 
loss modulus were measured in the linear-viscoelastic limit 148,149 and are shown in 
fig. 28. A temperature of 37 °C was selected for conducting experiments to mimic 
in vitro conditions. The results showed that each group is in a relatively stable gel 
state at 37°C (G¢>G¢¢ at any frequency) and the cryopreservation with any CPAs 
formulation only slightly altered the viscoelastic properties of alginate with some 
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differences when comparing the values of storage and loss modulus before and after 
freezing-thawing. On the contrary, both the storage (G¢) and loss (G¢¢) moduli of 
samples frozen in absence of any CPAs significantly increased (p<0.0001 for G¢ and 
p<0.001 for G¢¢ at 1 Hz) with respect to the values detected for the corresponding 
fresh gels. 
 
Figure 28. Left: frequency sweep rheological measurements comparing storage 
modulus (a) and loss modulus (b) of 2% wt alginate samples frozen in presence of 
the different cryoprotectants. Right: values of G’ and G’’ at 1 Hz. Error bars represent 
mean ± SD (n=3). **p<0.01 and ***p<0.001. Confidence levels are referred to the no 
CPA fresh group. Adapted from 144. 
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3.3.6 Liquid content 
In this study, we evaluated the influence of cryoprotectants and 
freezing/thawing on the liquid content of alginate hydrogel. After incubating 
hydrogel samples with the different CPAs, the samples were either rinsed in water 
or frozen, thawed and rinsed in water before measuring the liquid content. As 
shown in fig. 29, the equilibrium water content for fresh (non-frozen) hydrogels 
rinsed in water was not affected by any of the CPAs. On the contrary, we measured 
an about 2 points % decrease of the water content when the samples were frozen 
and thawed after incubation without using any CPA as well as a small decrease of 
the absorbed water for gels treated with glycerol or glycerol/trehalose. The water 
content decrease of the samples frozen without any CPAs agree with the observed 
increase of G¢ and G¢¢ previously reported. 
 
Figure 29. Liquid content study of alginate hydrogels after incubation with the CPAs 
(before freezing) and after incubation with the CPAs, freezing and thawing (after 
freezing). Error bars represent mean ± SD (n=5). **p<0.01 and ****p<0.0001. 
Confidence levels are referred to the relative before freezing counterpart for all the 
samples after freezing. Adapted from 144. 
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3.4 Discussion 
The issue of preservation and storage of encapsulated cells is an obstacle for 
translating cell encapsulation to tissue engineering in the form of commercial 
products 89,127,138. Cryoprotective agents (CPAs) are added during the freezing 
process in order to protect cells from cryodamages 131. DMSO and glycerol, in 
particular, penetrate cell membrane at physiological temperature and have been 
extensively used to prevent cell damage during cooling by minimizing intracellular 
ice formation 125,130. Furthermore, the addition of trehalose and other disaccharides 
to these cryoprotectants is known to enhance cell survival during cryopreservation 
of cell suspension 150 and engineered tissues 133,134. 
Many factors may influence cell viability in a cryopreservation system, 
including fabrication and freezing process, molecule diffusion kinetics in the 
hydrogel matrix, cell morphology and reorganization of the adhesion sites. 
Therefore, establishing a cryopreservation protocol for tissue-engineered products 
cannot disregard an analysis of the interaction between cells, encapsulating 
biomaterial, cryoprotective agents, freezing method and other conditions that may 
influence the cellular functionality and demands for an extensive investigation. In 
this study, we propose a systematic approach for assessing the impact of 
cryopreservation on engineered tissue, considering the analysis of cell recovery and 
of the material properties. 
In this work, we characterized the influence of cryopreservation on 
encapsulated cells, comparing the effect of different cryoprotectants on cell 
response after thawing. For this reason, sodium alginate hydrogel was chosen for 
encapsulating cells in order to reduce the interaction between cells and their 
encapsulating matrix. As a model, cells were entrapped in alginate fibers made by 
wetspinning, which represents a fast and high-throughput encapsulation model 29. 
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Cell-laden microfibers are easy to prepare, handle and assemble from an 
engineering standpoint and are appropriate to reconstruct structures with a 
hierarchical alignment 34. To validate the cryopreservation technique, MG-63 cell 
line was chosen as an established human osteosarcoma cell line for bone tissue 
engineering models with fully genetic characterization 151. After cell encapsulation, 
the hydrogel fibers were frozen in presence of different cryopreservation media 
containing DMSO, glycerol and trehalose, whose effects on cell functionality were 
compared after thawing. 
All CPA formulations successfully prevented the death of encapsulated cells 
during cryopreservation compared to cells frozen in absence of any 
cryoprotectants. The estimated post-thaw viability of cells encapsulated and 
cryopreserved with DMSO was 7% lower than in the non-cryopreserved group and 
15% higher than in the group cryopreserved with glycerol, and comparable to the 
results already published by other groups using the same freezing protocol 136. The 
addition of trehalose led to a decrease of cell viability that is larger for the group 
cryopreserved with DMSO, considering both the encapsulated cells and the control. 
We also monitored the viability of encapsulated cells up to 3 days after thawing in 
order to evaluate possible harmful effects of the CPAs that may remain in contact 
with the cells. In fact, high concentrations of cryoprotective chemicals can be toxic 
for cells, and toxicity must be reduced by decreasing the time of cell exposure to the 
cryoprotectants 125. The analysis of the Live/Dead data excluded protracted 
detrimental effect of the CPAs since appreciable cell death was not detected after 
the initial post-thawing observation. 
In order to develop methods to mitigate the harmful effect of 
cryopreservation on encapsulated cells, a detailed study of the possible pathways 
and mechanism leading to cell death is of primary importance. The exact 
mechanism leading to apoptosis and necrosis activated during freezing is not well 
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understood and remains to be studied 152. Moreover, the death pathway activated in 
one cell type might not be activated in other cell types. Cell cycle after thawing and 
releasing from the alginate matrix was compared with non-encapsulated protocol. 
Flow-cytometric analysis highlighted that both encapsulation in alginate and 
addition of trehalose reduced the viability of cells after cryopreservation. Besides, 
we observed a difference in cell-death pathway since the encapsulation led to later 
stage of apoptosis and necrosis of the cell population. A possible explanation is that 
the hydrogel acts as barrier that could cause a gradient of the cryoprotectant 
concentration in the fiber, so leading position dependent damage of cells and 
subsequent necrosis.  
The influence of the different cryoprotective formulation on cell metabolism 
and proliferation were investigated up to two weeks, since it has been reported that 
the effectiveness of cryopreservation cannot be reliably determined immediately 
after thawing 153. Moreover, a direct correlation between the viability (fig. 5) of a 
certain cell population and the ability of viable cells in that population to proliferate 
(fig. 6) and to be metabolically active (fig. 7) was not detected. 
Encapsulated cells, thawed and cultured in TCP, showed a larger metabolic 
activity and proliferative capacity when DMSO and glycerol alone were used as 
cryoprotectants. Indeed, a previous comparison of fibroblast response to low 
temperature in suspension and 3D culture indicated a more intense functional 
expression of stress proteins in 3D constructs 147. Interestingly, trehalose addition 
to encapsulated cells had a favorable effect on cell recovery when DMSO was used, 
and a reverse situation in the case of glycerol. This appears to be contrary to 
previous studies, which reported how the addition of sugars to cryoprotectants that 
penetrate cells at physiological temperature leads to a detectable improvement of 
the results in cryopreservation protocol for both DMSO 134 and glycerol 154. 
However, the abovementioned studies used different encapsulation materials and 
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freezing protocols than those used in the current work, and trehalose has been 
reported to possess inhibitory effects on proliferation of fibroblast-like cells in 
certain conditions 155. 
In our analysis, we detected an increased number of apoptotic cells 
corresponding to lower proliferation of the reseeded cells. A possible explanation is 
that Trypan blue method, that was used to counts the alive cells for the reseeding 
experiments, doesn’t discriminate between vital and early apoptotic cells 156. Thus, 
the real viable cells that are able to proliferate are less than those counted with the 
Trypan Blue exclusion method. Moreover, apoptosis has been reported to be 
responsible for a low cell recovery rate after cryopreservation 157. The relationship 
between the addition of trehalose and apoptosis could be attributed to various 
reasons and its clarification would require complex and laborious gene expression 
studies. Moreover, the effect of trehalose must be judged considering its complex 
interactions with the alginate matrix and DMSO/glycerol, that could affect its 
diffusion capacity from the medium to the cells. Besides, in our study DMSO better 
preserved the viability of encapsulated cells compared to glycerol; however, its effect 
(in absence of trehalose) resulted in increased apoptosis after thawing, 
corresponding to a diminished proliferation and metabolic capacity. This 
phenomenon can derive from the different ability of glycerol and DMSO to 
penetrate the alginate layer and interact with the cell membrane. This evidence 
highlights the importance of analyzing different cryopreservation protocols for 
different tissue constructs, in order to find the formulation that best adapt to the 
chosen cells and materials. 
Rheological analysis and liquid content measurement were performed in 
order to characterize the influence of cryopreservation on the viscoelastic and 
swelling properties of alginate hydrogel. In fact, these are critical features of 
hydrogels used in biomaterials and tissue engineering applications, influencing 
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both tissue morphogenesis and stem cell differentiation. A temperature of 37 °C 
was selected for conducting the experiments in order to mimic in vitro conditions. 
Based on our results, the values of tan(d) (higher than 0.2 at any frequency) reveal 
a clear viscoelastic behavior of the hydrogels. Moreover, it is clear that all the CPAs 
successfully preserved the viscoelastic properties of alginate after thawing, at the 
same time preventing the reduction of water content. We hypothesize that, during 
the freezing process, the presence of the CPAs can influence the growth of ice 
crystals from the water present in the matrix, thus affecting the conformational 
changes of the alginate network after thawing 120,158. In fact, the slow freezing process 
could generate concentrations fluctuations of the alginate content in solution, and 
this, thanks to the presence of residues of calcium, could results in a further 
crosslinking of the gel 159. Data on the water content (fig. 9) are consistent with the 
above assumption, as well as the increase of G¢ in alginate samples after freezing 
and the stiffness/frequency relationship (fig. 8). When CPAs are added, ice crystals 
formation is prevented and concentrations fluctuations are damped. The increase 
of the matrix rigidity could theoretically negatively impact the cells viability. 
However, this is a second order effect, being the intracellular ice formation the cause 
for the cells death. 
The collected data demonstrate that cells encapsulated in alginate fibers 
remained viable after cryopreservation in liquid nitrogen and thawing, hence stocks 
of cryopreserved cell-laden hydrogel constructs could be thawed when necessary 
and three-dimensionally assembled 34.  
The proposed method can be adopted to compare and select multiple 
cryopreservation parameters for a given system, including cryopreservation 
medium formulation, cell density, presence of adhesive motifs in the material and 
freezing rate. In fact, we evaluated the influence of different parameters on the 
efficacy of cryopreservation, including the use of different CPAs and the addition 
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of trehalose to the cryoprotective solution. Moreover, this protocol investigates the 
impact of encapsulation by comparing the results obtained for entrapped cells with 
those obtained for suspended cells. This work focused on evaluating the recovery of 
cells in terms of viability and functionality and the impact of freezing on the 
rheological properties and water content of the encapsulating hydrogel. The 
outcome of our research thus offers an approach to investigate the effect of 
cryopreservation on cell-laden hydrogel constructs, that can be adopted as support 
for different applications, from biofabrication to cell banking to drug releasing 
devices.  
3.5 Conclusions 
In summary, in the present work the possibility to cryopreserve cell-laden 
alginate fibers in presence of different cryoprotectants formulations was 
investigated. Encapsulated cells, when cryopreserved in presence of DMSO and 
glycerol, maintained a viability degree comparable to cells cryopreserved with 
standard protocols and no protracted harmful effect of the CPAs were observed 
after thawing. Furthermore, cryopreserved encapsulated cells expressed a faster 
recovery of functionality, confirming previous works 147. Overall, we propose a 
method to produce and store cell-laden hydrogel constructs that can serve as 
building blocks for subsequent assembly of tissue constructs according to different 
biofabrication strategies 25,50,160. 
Besides, in this paper we present an approach for the evaluation of the effects 
of cryopreservation on the functionality of cell-laden constructs. In fact, the 
protocol described herein proposes a method for determining the impact of 
cryopreservation on cell recovery and material properties after freezing in presence 
of different cryoprotectants, in short- and mid-term (up to 2 weeks after thawing). 
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The proposed approach can be adopted for evaluating the effect of other 
cryopreservation methods on cells encapsulated in specific hydrogel matrices and 
designed for specific applications. In fact, integration of cryopreservation 
techniques with cell micro-scale encapsulation introduces a promising approach to 
the field of tissue engineering and can be adopted as support for bottom-up 
engineered tissue assembly and cell banking, expansion and release 96,127. 
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Chapter 4.  
Engineering Hydrogels as Building Blocks: 
Evaluation of Alginate-based Films  
4.1 Abstract 
The use of hydrogels as building blocks for tissue engineering scaffolding and 
for the development of three-dimensional cell culture models requires the design of 
matrices with adequate geometry and physicochemical properties that resemble the 
native extracellular matrix (ECM). In fact, the composition of the hydrogels must 
be tuned in order to achieve cell proliferation and functionality inside materials that 
are compatible with microencapsulation technologies. 
In this study, a novel method for encapsulating cells within hydrogel films 
with micrometer thickness is described. MG63 osteoblast-like cells were 
encapsulated in alginate films, blended with different proteins (collagen type I, 
gelatin or silk fibroin) in order to enhance cell attachment, growth and 
functionality. The best matrix composition for supporting osteoblast cells was 
selected according to different parameters: cell metabolic (alamarBlue assay) and 
mitochondrial activity (CCK-8 assay), cell morphology and distribution (F-actin 
visualization) and vascular endothelial growth factor (VEGF) secretion (ELISA 
assay). 
Addition of proteins to alginate increased cell metabolic (up to 1.62 times for 
alginate-silk fibroin compared to pure alginate after 14 days) and mitochondrial 
(up to 1.75 times) activity, provided a suitable anchorage for osteoblast-like cells 
and enhanced the secretion of VEGF (up to 2.64 times after 72 hours). According 
to the results obtained in this study, alginate-silk fibroin hybrid hydrogel emerged 
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as the most promising hydrogel for osteoblasts encapsulation, thus representing a 
promising biomaterial for soft-tissue regeneration. 
The results proved that such novel hybrid hydrogels might find applications 
as building blocks for assembling complex cell-laden constructs or as support for 
co-culturing multiple cell populations. Moreover, the proposed alginate-based 
blends are promising biomaterial to produce osteoblast cells-laden matrices that 
can support vascularization. 
4.2 Introduction 
Extracellular matrix (ECM) is a complex tridimensional environment that 
provides structural support to cells and a regulatory milieu with a variety of 
important biological functions, including assembling cells into various tissues and 
organs, regulating growth and cell–cell communication 161. From a tissue 
engineering (TE) standpoint, encapsulating cells within modular culture 
environments and mimicking the complexity of specific cell niches found in vivo 
within hydrogel building blocks is desirable in order to replicate tissue functions in 
vitro 15,161. The engineering and assembly of tissue-mimicking 3D constructs, 
considering the intricate and organized nanoscale meshwork of native ECM, is 
important for tissue regeneration and other important applications of regenerative 
medicine 3,89. In fact, the biochemical and biophysical properties of the matrices that 
surround cells are essential to the functional tissue regeneration since cells can 
display different phenotypes depending on their microenvironment 162. A system 
that can mimic the structural architecture and biological functions of the 
extracellular matrix (ECM) in 3D should satisfy the following characteristics: have 
suitable mechanical properties, chemical composition and degradation kinetic, 
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support cell growth and maintenance, and facilitate nutrient, gas, metabolic waste 
transport, and signal transduction 2,161. 
Moreover, the natural interactions between different cell populations, in turn 
influenced by the extracellular environment, must be carefully taken into 
consideration. In fact, the cross-talk between two different cell types through cell 
signaling, growth factors and cytokines can have a profound effect on cell 
morphology, gene expression, differentiation and function 163,164. Co-culture 
methods – the culture of multiple, distinct cell types within the same environment 
– are used in tissue engineering and biofabrication to drive tissue formation with 
the interaction of multiple cell populations or to maintain the potency of stem cells 
during expansion 165. As an example, beyond the basic requirements, the hydrogel 
matrix used to encapsulate cells should also be able to support angiogenesis for an 
effective regeneration purpose in case of vascularized tissues, such as the bone 164,166. 
In fact, the association of vascular endothelial cells (ECs) and bone-forming 
osteoblasts (OBs) within three-dimensional constructs provide promising means of 
generating vascular bone tissue-engineered constructs. Therefore, encapsulated 
cells should express vascular endothelial growth factor (VEGF), the major 
angiogenic factor involved in physiological and pathological angiogenesis 81,164. 
So far two approaches for culturing multi-cellular systems have been 
proposed: direct co-cultures, which involve direct contact between the different cell 
populations that are mixed together within the culture environment; indirect co-
cultures, which involve the interaction, via soluble factors, between cell types that 
are physically separated within the culture environment 165,167. In the latter case, the 
complex dialogue among cell types within native tissue is recapitulated by signaling 
factors and cytokines that enrich the culture medium 165. Cells can be seeded on the 
scaffold or encapsulated in hydrogels either at the same time, for an homogeneous 
mix in the construct, or seeded at different times, which is beneficial if the two cell 
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lines have different proliferation rate 163 (fig. 30). Therefore, the engineering of co-
culture strategies for assembling complex multi-cellular constructs represent an 
important challenge for biofabrication, as these systems better model both 
physically and biologically the natural tissues. Building blocks must be conceived 
and designed considering the complex cell-cell and cell-biomaterial interactions, 
the specific physicochemical characteristic of native tissue and the precise needs of 
distinct direct or in-direct co-culture techniques 167. 
 
Figure 30. Different cell seeding strategies for co-culture system in tissue 
engineering. (A) Cells seeded together in the same construct at the same time point. 
(B) Cells seeded together in the same construct at different time points. (C) Cells 
seeded in different construct at the time start point and either cultured (i) together 
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or (ii) separately. (D) Cells seeded in different construct at different time points and 
either cultured (i) together or (ii) separately. Adapted from 163. 
Designing the cellular microenvironment remains one of the major challenge 
in tissue engineering, given the complexity of cell-ECM interactions as well as 
multicellular architectural features and the complex biochemical interactions 
between different cell types 161. The choice of the biomaterial is a critical element to 
enable survival, proliferation and function of the encapsulated cells. Moreover, the 
encapsulation method must be amenable to fabrication and assembly of complex 
3D structures in a manner that does not damage living cells 30. The research for 
novel biomaterials has shown the potential of hydrogels to mimic native ECM. 
Various technologies were developed to manufacture and assemble cell-containing 
microgels into designed architectures and spatial organizations 89. Hydrogels are 
considered an ideal matrix for culturing cells in three dimensions as they possess 
the capacity of incorporating bioactive molecules, such as growth factors, peptides 
and extracellular matrix components. In fact, chemical cues and topography of a 
scaffold are able to influence the proliferation, differentiation and function of the 
encapsulated cells and hence the quality of the final tissue substitute or tissue model 
168. In particular, the combination of proteins with alginate has proven to effectively 
modulate the physicochemical and biological properties of the hydrogel. The 
synergistic effect of multiple cues produces new hydrogels that exhibit a novel 
structure organization and new properties in order to expand the scope of their 
application in several areas of tissue engineering 162,169. 
Several different technologies have been used to produce cell-laden hydrogel 
building blocks that mimic specific cell niches; each technique have been tailored 
to reproduce a certain geometry, chemical cues, stiffness and application. The 
different hydrogels that can be utilized are limited within the range of techniques 
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available, based upon their mechanical properties and crosslinking methods 30. 
Furthermore, the range of possible geometries and form factors with which it is 
possible to manufacture building blocks are limited by nutrient perfusion and mass 
transport limitation issues. In fact, cell growth in 3D and engineered tissue are 
characterized by the limited diffusion of oxygen, nutrients, metabolites, waste 
products and signaling molecules, which are continuously produced and consumed 
by cells to support and maintain their function. 2D monolayer cultures do not 
mimic these physiologically relevant distributions. The mass transport of oxygen 
and nutrients is particularly critical because it limits proliferation of encapsulated 
cells cultures to distances less than a few hundred microns from oxygenated 
medium or, in living tissues, to similar distance from the nearest capillary 45,83. 
Therefore, the encapsulation of cells in hydrogel building blocks with features that 
exceed 100-200 µm represent a critical barrier for the manufacturing of relevant-
size tissue engineered constructs. Different approaches have been proposed to 
enhance mass transfer of nutrients, oxygen and waste removal in three-dimensional 
(3D) microenvironment with encapsulated cells. Alginate hydrogels are the 
materials most widely used for encapsulating cells within building blocks for 
biofabrication, because of its ability to form matrices which provides an aqueous 
environment necessary for sustainable cell growth. However, given the limited cell 
adhesion to alginate, as well as its uncontrolled degradation under physiological 
conditions, different methods have been proposed in order to functionalize or 
blend alginate with proteins and other bioactive molecules 169, as widely described 
in chapter 2. Hybrid hydrogels obtained by combining alginate with various 
proteins are expected to improve its biocompatibility and enhance cell adhesion to 
the matrix and functionality of the encapsulated cells. Among naturally occurring 
proteins, gelatin, collagen and silk fibroin are increasingly used in tissue 
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engineering applications, as they contain cellular binding motifs which support 
cellular attachment in a manner similar to ECM 122. 
4.2.1 Aim of the work 
The aim of this work was to design and characterize an innovative 
encapsulation method for cells in alginate hydrogel in the shape of films. These 
films were designed as building blocks for layer-by-layer assembling of hydrogel 
constructs. MG63 cells were encapsulated exploiting the surface tension of the 
liquid alginate, subsequently crosslinked in a calcium chloride solution. Hydrogels 
films are beneficial because their reduced thickness allows nutrients and oxygen to 
diffuse within the matrix to the encapsulated cells, therefore enabling cells to be 
cultivated in static conditions. Moreover, hydrogel films can provide a feasible 
support for either direct or indirect co-cultures systems. Three compounds were 
evaluated as blending agents to mimic the structural architecture and biological 
functions of the ECM, thus increasing cell attachment, proliferation and spreading 
inside the matrix: silk fibroin, collagen type 1, gelatin. The functionality of the cells 
inside the gel was evaluated in terms of metabolic activity, mitochondrial activity, 
secretion of vascular endothelial growth factors (VEGFs) and morphology 
(cytoskeleton/nuclei staining). 
Collagen is the most abundant protein in humans, being the main 
component of the ECM of many tissues, including skin, ligaments, cartilage, 
tendons and bone. Different classes of collagen exist, the type I being the most 
abundant and extracted from tissues by enzymatic and acidic treatment. Collagen 
protein possess a hierarchical structure, and consist of a unique triple helix 
assembled in a complex supramolecular structure (fig. 31) 5,170. 
 87 
 
Figure 31. Schematic diagram showing the hierarchical structure of collagen fibers. 
Three polypeptide strands (1) form a right-handed triple helix of collagen (2). These 
helical molecules furtherly assemble into collagen fibrils (3). Finally, collagen fibrils 
form as bundles of collagen fibers (4). Adapted from http://www.mun.ca/biology. 
Collagen is composed of specific combinations of amino acid sequences that 
are recognized by cells and can be enzymatically degraded in vivo. In particular, the 
high density of RGD sequences, an important tripeptide for the interaction between 
a variety of cells and the ECM, facilitate cell adhesion, migration and proliferation 
when in contact with collagen type I 170. Because of its biomimetic properties, 
collagen type I has found many potential applications in tissue engineering, as cell-
culture matrix or for the reconstruction of skin, blood vessels, cartilage and bone 
5,170.When the liquid solution is neutralized (e.g. with NaOH), collagen self-
assemble to form a hydrogel within 30-60 minutes at 37°C. Cells can be 
encapsulated during the gelation process by mixing them with the neutralized 
collagen solution and moving the suspension to an incubator 56. Collagen-based 
hydrogels are cytocompatible, amenable to cell adhesion without modifications, 
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and present a native viscoelastic environment to resident cells 3. Although collagen 
type I has been used as bioink, it suffers from some important drawbacks including 
low stiffness, limited long-term stability, slow gelation rate that makes bioprinting 
of 3D constructs difficult 3,39. Different collagen-containing hydrogel have been 
used for biofabrication and cell encapsulation applications and hybrid alginate-
collagen blends have been developed to serve as 3D bioprinting bioinks and to 
incorporate chondrocytes to construct in vitro 3D printed cartilage tissue 119. 
Gelatin is a soluble protein obtained by partial hydrolysis of collagen. The 
main sources of gelatin are pig skin, bovine hide, and pork and cattle bones. In order 
to produce gelatin, the collagen molecules undergo heat and chemical treatments 
that cleave both covalent and non-covalent bonds thus destabilizing the triple-helix 
and getting a single-strain water soluble molecule 5. Gelatin can be dissolved in 
water by heating the solution above 37°C, as the majority of the polypeptide chain 
are in a random coil conformation at body temperature. Gelation process (fig. 32) 
occurs cooling the solution and is based on a coil-to-helix conversion during which 
the single-strand molecules interact with each other to create helices similar to the 
collagen triple-helix 171. 
Gelatin has been used as a biomaterial because of its biocompatibility, high 
water-adsorbing ability, non-immunogenicity and degradability 52. Furthermore, 
because of its derivation from collagen, gelatin contain cell adhesion motif, which 
allows cells to recognize and adhere to gelatin-based matrices. As an example, 
Sarker and colleagues evaluated cell adhesive functionality conferred to alginate 
hydrogel either by blending or covalently cross-linking with gelatin 97. The presence 
of gelatin increased the degree of adhesion, spreading, migration, and proliferation 
of cell encapsulated in the alginate matrix. 
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Figure 32. Schematic representation of the gelatin gelation process driven by partial 
renaturation. When an aqueous gelatin solution is cooled down, the imino acid-rich 
segments of single-polypeptide chains begin to re-arrange into conformations that 
are similar to those in the collagen structure (shown in the inset). The 3D network 
structure is stabilized by lateral inter-chain hydrogen bonding within the helical 
regions. Adapted from 171. 
Silk Fibroin, a fibrous protein derived from Bombyx mori cocoons, is 
characterized by unique mechanical and architectural properties and is thus 
considered an attractive scaffold material for tissue engineering and cell 
encapsulation applications 169. Silks are a class of proteins synthesized by glands of 
arthropods such as silkworms, spiders, and scorpions. The silk that has been 
explored more extensively is derived from silkworms (i.e. Bombyx mori) 169,172,173. 
The larvae Bombyx mori uses the silk to prepare to enter the pupal phase enclosing 
themselves in a cocoon made up of a single silk fiber long around 1.5-2.5 km. The 
silk fiber is composed of two major protein, silk fibroin (core) and sericin (coating), 
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a hydrophilic glue-like glycoprotein wrapped around fibroin 173. Silk fibroin fibers 
are composed of building blocks of stable anti-parallel β-sheet crystallites held 
together by hydrogen bond and these hydrophobic domains are linked by small 
hydrophilic segment, the amorphous domain 173 (fig. 33). 
 
Figure 33. Structure and hierarchical organization of silk fibroin derived from 
Bombyx Mori. The silk fiber is composed of fibers of fibroin, a structural protein, 
held together by sericin, adhesive proteins. The fibroin fibers are produced from 
smaller-diameter nanofibrils made from assembled fibroin proteins. The fibroin 
proteins fold into a semi-crystalline morphology during spinning, being organized 
into highly crystalline β sheets and less-ordered domains. Adapted from 174. 
Sericin is removed by boiling silk cocoons in alkaline solution (a process 
called degumming) and the fibroin fibers are dissolved into an aqueous solution 
that can be further processed into different materials 172. The silk fibroin water 
solution is obtained disrupting the b-sheets by dissolution in a high molarity LiBr 
solution followed by dialysis against water to remove the salts. Li2+ and Br2+ ions 
interact with the crystalline region breaking the intermolecular hydrogen bond, 
which leads to a random coil state. Silk fibroin is water soluble after disruption of 
the crystalline structure, and forms a transparent solution, forming a gel through 
the conversion from random coil into β-sheet. The process occurs at lower pH, 
higher temperatures, and upon mechanical shear, vortexing, exposure to polar 
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solvents or ultrasonication 173,175. The gelation rate and the final stiffness are 
influenced by silk fibroin concentration, pH, temperature, and by parameters with 
which the fibroin is treated. Cells can be encapsulated during the gel formation, by 
using mild gelling conditions, such as crosslinking driven by genepin 176. 
Silk fibroin is characterized by highly repetitive amino acid sequences that 
provide to the natural fiber unique mechanical and biological properties 169, in 
particular the presence of cellular binding motif that could support cellular 
attachment in a manner similar to the ECM 177. Due to their excellent 
biocompatibility and favorable interaction with cells, silk fibroin-based 
biomaterials have been used for a variety of applications in tissue engineering and 
biofabrication, including drug delivery, vascular tissue regeneration, wound 
dressing and bone repair. Silk fibroin sponges can be used as three-dimensional 
porous scaffold to better mimic the tissue structure and can be formed using salt 
leaching, gas foaming and freeze-drying methods 173. Silk fibroin-based scaffolds 
have been investigated recently to explore their potentials in soft tissue engineering 
applications such as repairing ligaments, cartilage, primary nerves and skin 121. Silva 
and colleagues have reported the development of a hybrid hydrogel by blending 
alginate and silk fibroin solution in their liquid form and then inducing the gelation 
of alginate through ionic cross-linking. The combination of the polysaccharide and 
the protein leads to the formation of a hybrid alginate-based biomaterial, that 
retains alginate ease of gelation, structural integrity and non-immunogenicity with 
the addition of biological and adhesive properties of silk fibroin. They used this 
hybrid hydrogel to fabricate hydrogel substrates and hydrogel microcapsules. The 
presence of silk fibroin in the blend makes the gel stiffer compared with pure 
alginate, and improve the cell-adhesive properties of the blend 122,123. 
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4.3 Materials and Methods 
4.3.1 Materials 
The following materials were used: Bombyx mori silkworm cocoons 
(purchased from Chul Thai Silk Co., Phetchabun, Thailand); sodium alginate 
powder derived from brown algae, calcium chloride dihydrate, 0.05% Triton X-100, 
gelatin from porcine skin, Cell Counting Kit-8 (CCK-8) (Sigma-Aldrich, USA); 
collagen I from rat tail, VEGF Human ELISA Kit, DAPI (4',6-Diamidino-2-
Phenylindole, Dihydrochloride), Alexa Fluor™ 568 Phalloidin (ThermoFisher, 
USA); phosphate buffered saline (PBS), Minimum Essential Media (MEM), 200 
mM L-glutamine, 100 mM sodium pyruvate, 100´ MEM Non-essential Amino 
Acids, 100´ Antibiotic-Antimycotic solution, 0.05% Trypsin-EDTA solution; Fetal 
Calf Serum, Trypan Blue 0.4% solution (Lonza, Switzerland); MG63 osteosarcoma 
cell line (ATCC® CRL-1427™) (Istituto Zooprofilattico Sperimentale della 
Lombardia e dell’Emilia Romagna, Italy); Sonicator (UP400S Heilscher, Germany); 
4.3.2 Hydrogels preparation and sterilization 
Alginate. Alginate powder was dissolved in PBS overnight at room 
temperature to obtain a 2.5% (wt/vol) alginate solution. The crosslinking solution 
consisted in calcium chloride dihydrate dissolved in distilled water at a 
concentration of 200 mM. For sterilization, the two solutions were filtered through 
a 0.22-µm filter before use. 
Silk-fibroin. Silk fibroin was extracted from Bombyx mori silkworm cocoons 
with standard protocol (fig. 34). Initially, silkworm cocoons were cut and cleaned 
from debris and larvae. In order to remove the sericin content, the cocoons were 
degummed by immersing them at concentration of 10 g/L in a Na2CO3 solution of 
1.1 g/L at 98°C for 1h 30min, and then in a Na2CO3 solution of 0.4 g/L at 98°C for 
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1h 30min. The obtained silk fibers were dried at RT for 2 days. Silk fibroin fibers 
were then dissolved at a concentration of 20 g/100mL in a solution of lithium 
bromide 9.3 M at 60°C for 4h. The obtained solution was placed in a dialysis cassette 
with a cellulose membrane (35000 MW), and immersed for 5 days in distilled water 
at RT. The water was changed at regular intervals of time, three times per day. 
Subsequently, the cassette was transferred in PBS solution for 24 hours. The 
resulting solution was then filtered through a 0.22 μm filter under sterile conditions 
with a syringe. Silk fibroin concentration of the solution was assessed with a 
spectrophotometer measurement (NanoDrop, nd-1000). The final concentration 
was finally adjusted to 3% (wt/vol). 
Gelatin. Gelatin from porcine skin was dissolved in DI water at 37°C under 
mild stirring for 1 h to obtain a 3% (wt/vol) gelatin solution. The solution was then 
autoclaved. 
 
Alginate-based hydrogel precursors were prepared as follows (fig. 35): 
• Alginate-collagen type I blend (ALG-COL) was obtained by 
mixing 1 mL sterile collagen I from rat tail with 4 mL sterile alginate solution on ice 
and adjusting the pH by adding 0.025 µL of NaOH (2% (wt/vol) final concentration 
of alginate, 0.6% (wt/vol) final concentration of collagen). 
• Alginate-silk fibroin blend (ALG-SF) was obtained by mixing 1 mL 
freshly prepared silk-fibroin solution with 4 mL sterile alginate solution (2% 
(wt/vol) final concentration of alginate, 0.6% (wt/vol) final concentration of silk 
fibroin). 
• Alginate-gelatin blend (ALG-GEL) was obtained by mixing 1 mL 
of freshly prepared gelatin solution with 4 mL sterile alginate solution at 37°C (2% 
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(wt/vol) final concentration of alginate, 0.6% (wt/vol) final concentration of 
gelatin). 
• Alginate (ALG) was obtained by mixing 1 mL of PBS with 4 mL 
sterile alginate solution (2% (wt/vol) final concentration of alginate). 
 
Figure 34. Schematic of the silk fibroin extraction procedure. Going from the raw 
material (cocoons) to the final aqueous-based solution took 10 days. Note that some 
steps have been modified to adapt to experimental needs. Adapted from 172. 
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Figure 35. Summary of the produced samples and the different materials that were 
used. 
4.3.3 Cell culture and encapsulation 
MG63 osteosarcoma cells were thawed and expanded using standard 
protocols. In particular, cells were expanded in tissue-culture treated flasks as 
monolayer at 37°C under 5% CO2 to 85-90% confluence before encapsulation. 
Culture medium was composed of MEM containing 10% fetal bovine serum 
(GIBCO), 2mM glutamine, 1 mM sodium pyruvate, 1% non-essential amino acids 
and 1% Antibiotic Antimycotic solution. At sub-confluence cells were detached 
from the flask with the Trypsin solution. Subsequently, cells were centrifuged at 
1000 rpm for 10 minutes, rinsed in PBS to remove any residues of culture medium 
and finally dispersed by vortexing inside the buffer. An aliquot of the suspension 
was used to determine cells concentration using a hemocytometer (Sigma, USA) 
and Trypan Blue 0.4% as contrasting agent. Cells were centrifuged again and, after 
removing the supernatant, resuspended in the proper amount of alginate-based 
solution to obtain a suspension containing 4´106 cells/mL. 
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Cells were encapsulated in alginate films through a single-step process under 
a laminar-flow hood (fig. 36). A stainless-steel ring with inner diameter 10 mm was 
autoclaved, immersed in ethanol and rinsed in DI water. The ring was then 
immersed in one of the alginate-based solution containing cells and immediately 
extracted and immersed in the crosslinking solution containing calcium ions for 
about 10 seconds, causing the cell entrapment into the already gelled thin disk. The 
film was then detached from the metal ring with the aid of metal autoclaved 
tweezers and transferred to a TCP. After few minutes, crosslinking solution was 
discharged and fresh medium was added in each well to cover the films. The 
samples were then incubated at 37 °C with 5 % CO2. 
 
Figure 36. Formation of the alginate-based films containing cells. A representative 
alginate-based solution has been stained blue (a). A stainless-steel ring is immersed 
in the alginate blend solution (b) and, when extracted, a film is formed inside the 
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ring due to surface tension (c). The ring is then immersed in the crosslinking 
solution containing calcium ions (d) for 10 second and, when extracted, the film 
gelates inside the ring (e). The film is finally removed from the ring with the aid of 
tweezers (f). Representative image of the dimensions of the film (g). 
4.3.4 In vitro evaluation 
In vitro evaluations were performed on encapsulated cells up to 14 days. 
During this time, the alginate-based hydrogel films containing cells were cultured 
in 48 well-plates. The complete scheme of the experiments is reported in fig. 37. 
 
Figure 37. Schematic of the performed assays and relative time points. 
Cells metabolic activity. At different time points after cell encapsulation (1, 
3, 7, 10 and 14 days), the metabolic activity of the encapsulated cells was evaluated 
with alamarBlue assay, which uses the reducing power of healthy cells to convert 
resazurin to the fluorescent molecule resorufin. The alginate-based films containing 
cells were incubated for 2 h in the dark with culture medium containing 10% 
alamarBlue. Subsequently, 100 L of supernatant from each sample was transferred 
into a well of a 96 well-plate and fluorescence intensity was measured in triplicate 
on a plate reader (535±25 nm excitation and 590±20 nm emission; Spark 10M, 
Tecan, Switzerland). 
Cells mitochondrial activity. At different time points after cell encapsulation 
(1, 3, 7, 10 and 14 days), the mitochondrial activity of the encapsulated cells was 
evaluated with Cell Counting Kit-8 (CCK-8) through the enzymatic conversion of 
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tetrazolium salt. The water-soluble tetrazolium salt, WST-8, is bioreduced by 
cellular dehydrogenases to an orange-color formazan product that is soluble in 
tissue culture medium. The amount of the formazan dye, generated by the activities 
of dehydrogenases in cells, is directly proportional to the number of living cells. At 
the different time points, culture media were completely removed from the samples 
and freshly prepared culture medium containing 10 % (v/v) CCK-8 assay kit was 
added, followed by incubation for 2 h in the dark. Subsequently, 3x100 µL of 
supernatant from each sample was transferred into a 96 well-plate absorbance 
measurement at 450 nm with a microplate reader (Spark 10M, Tecan, Switzerland) 
VEGF release. Vascular endothelial growth factor (VEGF) secretion from the 
encapsulated cells was measured by performing a quantitative solid-phase sandwich 
Enzyme-Linked Immunosorbent Assay (Human VEGF ELISA Kit) using the 
culture medium as substrate. 24 and 72 h after cell encapsulation, the culture 
medium was collected and stored up to -20°C before assaying according to 
manufacturer’s instructions. Subsequently, the total VEGF secreted in the first 3 
days from the cells encapsulated in the different alginate-based hydrogel film was 
evaluated with the ELISA method. This assay requires a compatible antibody pair 
that recognize different antigenic targets (epitopes) on the same antigen. The first 
antibody, VEGF-165 called capturing antibody, was coated on a plate and used to 
immobilize the VEGF upon binding during incubation with the sample. Free 
proteins were removed by a washing step and then a biotinylated detecting antibody 
was added to bind to a second epitope-binding site on the VEGF. After washing 
away unbound biotinylated antibody, horseradish peroxidase (HRP)-conjugated 
streptavidin was pipetted to the wells. The wells were washed again, a 
Tetramethylbenzidine (TMB) substrate solution was added to the wells and 
colorimetric signal developed in proportion to the amount of target protein bound. 
The Stop Solution changed the color from blue to yellow, and the optical density of 
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each well was determined using a microplate reader (Spark 10M, Tecan, 
Switzerland) at 450 nm test wavelength (550nm used as reference). A calibration 
curve was built up using the VEGF standard provided with the assay to correlate 
absorbance intensity to VEGF concentration. For each test nine replicates were 
used. 
Evaluation of cell morphology and distribution. After 14 days of culture, 
cell distribution was evaluated by staining the samples with Alexa Fluor™ 568 
Phalloidin and DAPI (4',6-diamidino-2-phenylindole), which selectively binds to 
cytoskeleton F-actin and nuclei respectively. The alginate-based films containing 
cells were washed twice with PBS and then fixed in 4% paraformaldehyde (PFA) for 
20min at room temperature. After washing twice with PBS, the samples were stored 
at 4°C overnight. Subsequently, cell membranes were permeabilized with Triton X-
100 (Sigma-Aldrich, USA) solution (0.2 % in PBS) for 30 min and then washed 
twice in PBS. For the staining, a solution of DAPI (300 nM in PBS) and Alexa Fluor™ 
568 Phalloidin (5 µL of stock solution for each sample) was added to the samples 
and stored for 30 minutes at room temperature in the dark. The samples were then 
washed twice with PBS and the images were acquired through a confocal 
microscope (Nikon A1, Japan). The cytoskeletons fluoresce red since Alexa Fluor™ 
568-conjugated Phalloidin selectively label F-actin. DAPI binds strongly to A-T rich 
regions in DNA, thus staining blue the cell nuclei. Confocal images were collected 
along the Z-axis with 10 µm intervals (405 nm excitation, 460/10 emission for 
DAPI; 560 nm excitation and 595/25 emission for Alexa Fluor™ 568 Phalloidin). 
Statistical analysis. Graphpad Prism 7 software was used for statistical 
analysis. Results are expressed as mean ± standard deviation (SD) and significance 
was tested using two-way analysis of variance with Tukey’s range test. A p value of 
0.05 was considered significantly different. 
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4.4 Results and discussion 
Cell-compatibility of materials used for encapsulating cells critically affects 
the subsequent fate of biofabricated and assembled constructs. Therefore, soft 
materials that support cell attachment, proliferation, and function are needed for 
cell encapsulation in novel applications for regenerative medicine applications. 
Pure alginate hydrogel has been proved to be a suitable material for micro-
encapsulation, as it provides an aqueous environment necessary for nutrients and 
metabolites exchange. However, it does not promote cell adhesion and often does 
not support cell proliferation and metabolic function. Modification of the hydrogel 
composition by adding different molecules such as native protein components or 
peptide sequences is thus expected to improve biocompatibility of alginate-based 
matrices. In fact, incorporation of cell-adhesion ligands enables cell-matrix 
interactions and leads to an increased cell functionality and matrix remodeling 81,122. 
The most widely investigated method for alginate modification has been the 
incorporation of bioactive molecules, such as gelatin and RGD (Arg-Gly-Asp) 
sequence, into oxidized alginate. However, the chemical modification process 
involves several steps, being relatively expensive and time consuming.  
In this work, we present an innovative method to fabricate alginate-based 
hydrogel films containing cells by exploiting the surface tension of liquid alginate. 
This strategy could enable culturing multiple cell types in different films, 
controlling the molecular distribution of the bioactive molecules within the matrix, 
and the subsequent stack of the films in order to obtain ticker constructs. The films 
can be used as feasible support for assembling constructs containing multiple type 
of cells, since the specific geometry of the films is suitable for 3D/3D co-culture and 
for hybrid 2D/3D co-culture. Furthermore, the multi-cellular system can be 
spatially and temporally modulated, in order to cultivate cells directly in the same 
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construct or indirectly by enabling the solely interaction via soluble factors. 
Ultimately, this strategy can be useful to study the interaction between different cell 
types as well as to manufacture complex tissue models in order to test drugs and 
therapeutics. As an example, a functional 3D layered model could be beneficial to 
probe multi-layered neural circuits, enabling a better understanding of traumatic 
brain injuries (TBI) as well as performing preliminary evaluation of new therapeutic 
treatments30. As an example, the engineering of functional skin requires stratified 
skin cellular structures that are crucial for the regeneration of cell-to-cell and cell-
to-extracellular matrix interactions. Therefore, three-dimensional (3D) 
organotypic reconstruction of multiple skin layers has been suggested for skin 
repair and to model progresses of skin diseases or damages 46. Moreover, hydrogel-
based constructs in the shape of film are beneficial as cardiac patch 178 and as 
support for cell-sheets technique 179. 
MG63 cells, an established osteoblast-like cell line for bone tissue engineering 
models with fully genetic characterization, were encapsulated in the films 151. In 
order to support proliferation and functionality of the encapsulated cells, different 
nature derived proteins were incorporated during hydrogels formation. The 
experimental campaign focused on the evaluation of the effect of the different 
hydrogels, in order to identify the best formulation in terms of cell proliferation, 
metabolic activity, adhesion and functionality. In particular, as osteoblast have been 
widely used in combination with endothelial cells for bone tissue engineering 
applications, the secretion of VEGFs was investigated 81. 
When immersed in the alginate-based solution containing cells, a thin film 
formed within the metal ring due to surface tension. Upon immersing the ring in 
the crosslinking solution containing calcium ions, the solution gelled thus 
entrapping the cells inside the film. Cells appeared homogeneously distributed 
inside the films. The mean thickness of the films, measured by optical microscopy, 
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is 248±13 µm (n=9), which is compatible with nutrients diffusion in presence of 
high cell densities 27. In fact, according to the in vitro measurements in 3D 
spheroids, reported by Gasperini et al. an oxygen diffusion limit of 250 µm was 
observed experimentally, indicating that the encapsulated cell behavior was 
unlikely influenced by hypoxia and the differences between pure alginate and 
alginate/protein hydrogel films resulted from the presence of the proteins 27. 
Importantly, a single hydrogel film containing cells is sufficiently strong 
mechanically that it can be easily manipulated and stacked into multiple-layer 
constructs to generate 3D cultures. Therefore, it is possible to assemble 3D cultures 
of cells controlling the properties of the construct at the µm length scale. 
4.4.1 Cell metabolic activity 
Quantitative assessment of the metabolic activity of MG63 cells encapsulated 
in alginate-based hydrogel films over 14 days of incubation is shown in figure 38. 
The absolute values show a growth trend of cell metabolic activity during all the 14 
days of the experiment (fig. 38 a). At each time point the cells of the ALG-SF group 
are those that exert the greatest metabolic activity, followed by those of the ALG-
GEL, ALG-COL and ALG group. Observing the normalized data compared to the 
samples containing only alginate (fig. 38 b), it is highlighted that one day after cell 
encapsulation there is the maximum difference between the groups (increment of 
282±22 % for ALG-SF, 239±13 % for ALG-GEL, 149±19 % for ALG-COL). By 
increasing the incubation period, the difference between the groups tends to 
decrease, and in fact at day 14 all the samples containing proteins in the gel have a 
comparable cellular metabolic activity value. However, a statically significant 
difference with respect to samples containing only alginate persists (increment of 
162±11 % for ALG-SF, 154±3 % for ALG-GEL, 151±2 % for ALG-COL).  
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(b) 
 
Figure 38. Metabolic activity of MG63 cells after 1, 3, 7, 10 and 14 days of incubation, 
encapsulated in alginate (ALG), alginate-collagen (ALG-COL), alginate-gelatin 
(ALG-GEL), alginate-silk fibroin (ALG-SF). (a) Total values (b) Fold change relative 
of pure alginate (ALG) values. Error bars represent standard deviation (n = 7). *p < 
0.05, ***p < 0.001 and ****p < 0.0001. 
This behavior can be explained by the formation of cell-matrix contacts in the 
hydrogel film in presence of proteins, leading to more functional cells immediately 
after encapsulation. However, since the proteins had not been covalently linked to 
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the polysaccharide matrix, part of the bioactive molecules is released from the gel 
during incubation, thus justifying the reduction of the difference between the 
groups in the long term. Moreover, since the different proteins have different 
diffusive capacities within the hydrogel matrix, the functionality of the cells can be 
explained in quantitative terms as well as for the different effect that the bioactive 
molecules have in establishing cell-matrix contacts. 
4.4.2 Cell mitochondrial activity 
Quantitative assessment of the mitochondrial activity of MG63 cells 
encapsulated in alginate-based hydrogel films over 14 days of incubation is shown 
in figure 39. Mitochondrial activity is an important aspect of normal cellular 
function, playing an important role in cell proliferation, apoptosis or cell death and 
hence in regulation of the cellular functions 123. The absolute values show a growth 
trend of cell metabolic activity during all the 14 days of the experiment (fig. 39 a), 
and these results are in accordance with the above described results of the metabolic 
activity. In fact, at each time point the cells of the ALG-SF group are those that exert 
the greatest metabolic activity, followed by those of the ALG-GEL, ALG-COL and 
ALG group. According to the normalized data compared to the samples containing 
only alginate (fig. 39 b), the maximum difference between the groups was detected 
one day after cell encapsulation (increment of 331±69 % for ALG-SF, 252±38 % for 
ALG-GEL, 112±15 % for ALG-COL). After 14 days of incubation, the 
mitochondrial activity of cells immobilized in presence of proteins was significantly 
higher compared to those grown in the pure alginate constructs (increment of 
175±10 % for ALG-SF, 161±6 % for ALG-GEL, 120±10 % for ALG-COL). 
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Figure 39. Mitochondrial activity of MG63 cells after 1, 3, 7, 10 and 14 days of 
incubation, encapsulated in alginate (ALG), alginate-collagen (ALG-COL), alginate-
gelatin (ALG-GEL), alginate-silk fibroin (ALG-SF). (a) Total values (b) Fold change 
relative of pure alginate (ALG) values. Error bars represent mean ± SD (n = 7). *p < 
0.05, **p < 0.01, ***p < 0.001 and ****p < 0.0001. 
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4.4.3 VEGF release 
In figure 40, the VEGFs release from MG-63 cells encapsulated in alginate-
based hydrogel after 72 h of cultivation is shown. Numerous studies have 
demonstrated the critical role of vascularization in successful tissue integration 
during bone fracture repair. VEGF is well known as an effective endothelial cell-
specific stimulus, that can regulate endothelial tube assembly through a local 
paracrine effect. It is constitutively expressed by osteoblast and osteoblast-like cells 
(e.g. MG63), thus playing a fundamental role in cell-to-cell communication 
between osteogenic and endothelial lineages during the vascularization process of 
bone-tissue engineered constructs 73,164,180. The release of VEGF from immobilized 
cells in soft matrices should correlate with the observed increased in the angiogenic 
potential of such constructs 181,182. The amount of expressed VEGF in cells 
immobilized in a hydrogel constructs could depend on the chemical composition 
of the matrix as well as on the micro-environmental conditions (cell density, 
diffusion of oxygen and nutrients, presence and concentration of other regulating 
factors in the culture medium) 81. According to the present study, enhanced VEGF 
secretion from osteoblast-like cells was measured in the cell culture medium from 
alginate-protein matrices over 3 days of cultivation compared with pure alginate 
films. In particular, significantly higher VEGF secretion was measured in the cell 
culture medium from cells encapsulated in presence of silk fibroin and gelatin 
(increment of 264±44 % for ALG-SF, 246±33 % for ALG-GEL, 160±18 % for ALG-
COL).  
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Figure 40. Vascular endothelial growth factor released from MG-63 cells 
immobilized in alginate-based hydrogel films after 72 h of incubation: alginate 
(ALG), alginate-collagen (ALG-COL), alginate-gelatin (ALG-GEL), alginate-silk 
fibroin (ALG-SF). Fold change relative of pure alginate (ALG) values *p<0.05, 
****p<0.0001 compared with ALG. 
These results confirm those that emerged from the analysis of cell metabolic 
and mitochondrial activity, and the observed VEGF release profile can be explained 
by the increased activity of the cells, triggered by the presence of cell-matrix 
adhesion sites. In fact, other studies have shown a direct correlation between cell 
viability and metabolic activity with an increased secretion of VEGF from osteoblast 
like-cells, as for example Grigore et al. who evaluated the used of alginate-gelatin 
and alginate-RGD matrices to encapsulate MG63 cells 81. 
4.4.4 Cell morphology and distribution 
The morphology of MG63 cells entrapped in alginate-based hydrogel films 
was studied by fluorescent staining with Alexa Fluor™ 568 Phalloidin and DAPI, 14 
days after encapsulation. Cell distribution in 3D was examined using confocal 
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microscopy and the resulted images are reported in fig. 41. Cells were found to be 
uniformly distributed through the whole film in all four hydrogel formulation films. 
We observed that cells entrapped in pure alginate hydrogel maintained a spherical 
morphology. Even cell clusters, which identify cell proliferation sites, were seen to 
be spherical, in accordance to our expectations considering the poor adhesion-
capacity of alginate. The addition of collagen to the alginate did not provide any 
improvement in the cell-proliferation capacity of the hydrogel, confirming the 
result of cell mitochondrial activity. However, alginate-collagen promoted the 
protrusion of small actin filaments in the surrounding matrix, even if cells 
maintained their spherical shape. Cells encapsulated in alginate-gelatin and 
alginate-silk fibroin displayed multiple elongated protrusion and even formation of 
cell-cell contact over distance of 100 µm. Significantly more cells were found in 
these films, thus suggesting that SF and gelatin can provide a proliferation-
supporting environment for osteoblast-like cells. These findings are in accordance 
to the cell mitochondrial activity data, showing that both cell–material and cell–cell 
contacts lead to increased cell viability. Cells immobilized in presence of gelatin 
formed compact aggregates while, on the contrary, cells encapsulated in presence 
of silk fibroin tend to form randomly shaped clusters and cell chains. 
These results suggest that silk fibroin can provide a suitable anchorage and a 
growth-supporting environment for these osteoblast-like cells, as the initial 
attachment of cells promotes cell survival and plays a role in regulation of cell 
function and signaling 81,97. Nevertheless, it is worth mentioning that the elongation 
of the cell clusters observed in the hydrogel formulations containing proteins is not 
a sign of strong cell–matrix adhesion. By contrast, different groups observed that 
the cross-linking of alginate with proteins or bioactive peptide sequences facilitated 
a better cell adhesion, as they noticed better cell spreading and migration in 
comparison to the alginate-proteins blends 97. 
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Figure 41. Confocal microscopy of MG-63 cells immobilized in alginate-based 
hydrogel films after 14 days of incubation: alginate (ALG), alginate-collagen (ALG-
COL), alginate-gelatin (ALG-GEL), alginate-silk fibroin (ALG-SF). Cells were 
stained for the F-actin cytoskeleton with Alexa Fluor™ 568 Phalloidin (red) and 
nuclei with DAPI (blue). All scale bars are 100 µm (top images) or 250 µL (bottom 
images). 
Gathering these results, it is possible to conclude that alginate-silk fibroin 
blend presents superior MG63 cell compatibility compared to pure alginate and 
alginate blended with collagen. After 14 days of incubation, the behavior in terms 
of metabolic and mitochondrial activity was comparable with cells encapsulated in 
alginate-gelatin gel, but in the case of silk fibroin cells presented more randomly 
shaped clusters thus suggesting the presence of an environment more favorable to 
cell adhesion. Interestingly, the release of VEGF from cells encapsulated in ALG-SF 
within the first 3 days of incubation suggests that this matrix, in combination with 
osteoblast or osteoblast-like cells, may provide a support for vascular tissue 
regeneration applications. In fact, VEGFs are well known as a regulatory signal for 
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endothelial tube assembly. In future studies, endothelial cells could be used in 
combination with osteoblast cells in order to validate the use of alginate-based films 
as matrices that support vascularization. Further studies will be necessary to 
evaluate the cell–cell and cell–material interactions of the endothelial cells after film 
formation process, as well as the mechanical stability and behavior of such 
constructs. Alternative interesting applications include cell delivery and 3D models 
for cell culture and drug screening. Furthermore, the proposed geometry can serve 
as support for manufacturing cell-sheet in order to facilitate handling and assembly 
procedure 17. 
Several challenges should be addressed before hydrogel film-based tissue 
constructs can be used in biofabrication approaches for regenerative medicine. 
Different methods to manipulate and stack multiple films must be evaluated, as well 
as the use of bioreactors in order to support a biologically active environment 
within multiple-layered constructs. The physico-mechanical properties of the films 
should also be determined to understand the in vitro degradation mechanism. 
Moreover, the mechanical properties of hydrogels itself should be improved by, for 
example, the creation of nanocomposites with nanoscale inorganic fillers. In 
addition, the degradation of cross-linked materials should be adapted to the in-situ 
formation of ECM. The adoption of these materials for biofabrication procedures – 
for example, cell printing processes – to create hierarchically and intra-complex 
porous architectures for tissue mimicking constructs, should be further 
investigated. 
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4.5 Future Directions 
Future work will focus on the integration of the proposed matrices, 
containing osteoblast-like cells (OBs), with endothelial cells (ECs) in order to 
develop vascularized constructs. 
Initially, Human Umbilical Vein Endothelial Cells (HUVECs) will be used as 
cell line model for endothelial cells. Different cell seeding strategies for the two cell 
populations will be evaluated, ranging from seeding the cells together in the same 
film to developing hybrid 2d-3d matrices (one cell line encapsulated within the film 
and the other seeded on top of it). In fact, MG63 cell-laden films should act as a 
biological substrate for HUVECs adhesion and promote their proliferation and 
organization in capillary-like networks, due to the release of proangiogenic factors. 
The ability of the two cell lines to cross-talk by paracrine signaling and cell-to-cell 
contacts will be characterized. As an example, ELISA assay and gene expression 
PCR will be used to assess the expression and release of paracrine molecules that 
can trigger the expression of gene markers for the bone tissue and for neo-
angiogenesis processes. 
Subsequently, multiple alginate-based hydrogel building blocks containing 
ECs and OBs will be stacked layer-by-layer to generate pre-vascularized constructs 
that can serve for bone tissue engineering or as a bone unit model. In this 
framework, the ability of different films to self-assemble and the ability of cells to 
migrate within the assembled constructs will be evaluated. Finally, assembled 
constructs might be moved to a perfusion bioreactor in order to ensure the oxygen 
supply and physical cues to the cells during the initial phases of tissue maturation. 
The composition of the alginate-based hydrogel matrix, the cell seeding 
strategy and the parameters for cultivating cell-laden films and the assembled 
constructs will be tuned and adapted according to the obtained results. 
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4.6 Conclusions 
In the present study, an innovative method to manufacture micrometer-
thickness films containing living cells has been proposed. This technique potentially 
enables the biofabrication of multiple-layer constructs composed of different layers, 
each of them designed to maximize the compatibility with the encapsulated cell 
type. Moreover, the proposed geometry can be adapted as support for 
manufacturing constructs containing multiple cell types according to different 
direct and indirect methods. Potentially, this technique can be used to biofabricate 
clinically-relevant sized soft tissue models with complex and multi-cellular 
structures. In order to improve cell behavior, the current study has proposed the 
use of alginate blended with protein solutions (collagen, gelatin, silk fibroin) for cell 
microencapsulation.  
The results of our comparative analysis demonstrated that overall best 
compatibility with osteoblast-like MG63 cells was observed for silk fibroin-
containing alginate hydrogel, which promoted cell attachment, growth, and 
functionality. In particular, the incorporation of silk fibroin within the matrix 
promoted the secretion of VEGFs from the encapsulated cells. The proposed hybrid 
hydrogel thus represents a promising candidate for supporting the fabrication of 
vascularized cell-laden hydrogel constructs. Further studies will investigate the use 
of other material combinations and their applicability as soft matrices for more 
complex biofabrication approaches and different areas of tissue engineering. 
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